PROFILE

Prof. Pravir Kumar is a distinguished academician and researcher with over 22 years of experience in teaching and research, particularly in the areas of vascular biology, molecular neuroscience, and drug discovery. He currently serves as Professor in the Department of Biotechnology and Dean of International Affairs at Delhi Technological University (DTU). He has previously held several key administrative/academic positions, including Dean of Alumni Affairs and Head of the Department of Biotechnology at DTU. His research expertise encompasses protein aggregation, molecular chaperones, and ubiquitin E3 ligases in neurodegenerative disorders, along with investigations into aberrant cell cycle re-entry in aging neurons and muscle tissues. Dr. Kumar has an impressive academic record, with over 250 publications in peer-reviewed journals and conference proceedings, more than 7300+ citations, an h-index of 41, and an i10-index of 80. He has supervised more than 20 Ph.D. scholars and mentored over 150 Master's students. Prof. Kumar earned his M.S. in Molecular and Clinical Genetics from Banaras Hindu University (BHU), Varanasi, and completed his Ph.D. at J.W. Goethe University, Germany, focusing on coronary artery diseases and cardiovascular physiology. His postdoctoral research was conducted at the Department of Neurology, Tufts University School of Medicine, Boston, USA, where he also held a junior faculty position.

Before joining DTU, he served as Associate Professor (SBST) and Assistant Director at the Centre for Medical Engineering, Vellore Institute of Technology (VIT), an Institution of Eminence (IoE).

Prof. Kumar has contributed significantly at the national level as well. He served as a National Expert Member for the Soldiers' Health and Drug Discovery (SHDD) program under the Defence Research and Development Organization (DRDO), Ministry of Defense, Government of India. He has been part of several prestigious panels, including the Fulbright Scholarship Selection Committee, Indian Council of Medical Research (ICMR), and the Ministry of Health. He has also undertaken confidential advisory roles for the Government of India. Additionally, Prof. Kumar serves on the editorial and reviewer boards of over 85 international journals, including those under the Nature Publishing Group and a sole editorial member from India in highly reputed journal Ageing Research Reviews (Elsevier).

Research Area:

Molecular Medicine, Ubiquitin E3 Ligase and Molecular Chaperones, Molecular Neuroscience (Alzheimer's and Parkinson's disease), Signal Transduction/Cellular Signalling, Metabolomics, Spatial Transcriptomics, Neurooncology, Redox biology, Drug discovery and screening, Functional genomics and Cancer biology, Cardiovascular physiology, AI/ML, Big data.

 

PREVIOUS POSITIONS/ EXPERIENCE

INSTITUTION AND LOCATION

POSITION or
DEGREE RECEIVED

YEAR(s)

FIELD OF STUDY

Delhi Technological University
(Formerly Delhi College of Engineering)

PROFESSOR

July 2015-present

Neurobiology and Molecular Medicine

Delhi Technological University
(Formerly Delhi College of Engineering)

DEAN (INTERNATIONAL AFFAIRS)

Sep 2022-present

Senior level administration and policy making at University level

Delhi Technological University
(Formerly Delhi College of Engineering)

CHAIR/HEAD OF THE

DEPARTMENT

Jan 2021-Dec 2023

Senior level administration and policy making at Department and University level

Delhi Technological University
(Formerly Delhi College of Engineering)

DEAN

(ALUMNI AFFAIRS)

Jan 2018-March 2020

Senior level administration and policy making at university level

Delhi Technological University (Formerly Delhi College of Engineering)

Associate Professor

July 2012-July 2015

Neurobiology and Molecular Medicine

Adjunct Faculty, Tufts University School of Medicine, Boston, MA USA

Adjunct research instructor

August 2009-Jun 2016

Neurobiology and Molecular Medicine

VIT University, Vellore TamilNadu

Assistant Director, Centre for Medical Engineering

Jan 2011-July 2012

Neurobiology and Molecular Medicine,

middle management

VIT University, Vellore TamilNadu

Associate Professor

Jan 2009-July 2012

Neurobiology and Molecular Medicine

VIT University, Vellore TamilNadu

Assistant Professor

Nov 2008- 2009

Neurobiology and Molecular Medicine

Tufts University School of Medicine Boston MA

Research Instructor in the Faculty of Medicine

2007-

2008

Medicine/Neurobiology

Supervisor: Henry W. Querfurth
Chief: Allan H. Ropper

Tufts University School of Medicine Boston MA

Senior Research associate and Postdoctoral Fellow

2004-

2007

Medicine/Neurobiology Supervisor: Henry W Querfurth Chief: Allan H. Ropper

J. W. Goethe University Frankfurt/Main, Germany

Ph.D. BAT II/2 position

2001-

2004

Medicine/ Cardiology Mentors: Rudi Busse and Ingrid Fleming

J. W. Goethe University Frankfurt/Main, Germany

Diploma with Thesis

1999 -2001

Molecular and Cell Biology

Mentor: Lutz Nover

Banaras Hindu University
Varanasi, India

MS

1997-

1999

Zoology, with specializations in Molecular, Applied, and Clinical Genetics
 

TEACHING (COURSES TAUGHT)

SUBJECTS TAUGHT

CLASS

Genetic Engineering

M.Sc. Biotechnology 2019-2021

Molecular Therapeutics

M.Sc. Biotechnology 2019-2021

Gene therapy

M.Tech. Biomedical Engineering 2019-2021

Application of genomics in Medicine Theory and Lab

Master of Technology (M.Tech.) Bioinformatics 2014-current@DTU

Advanced Genetic Engineering

Master of Technology (M.Tech.) Bioinformatics 2014-Current @DTU

Human Anatomy and Physiology Theory and Lab

Master of Technology (M.Tech.) Bio-medical Engineering, 2013-current@DTU

Advanced Proteomics

Master of Technology (M.Tech.) Bioinformatics 2013-current @DTU

Protein Engineering

Master of Technology (M.Tech.) Industrial Biotechnology 2013-current @DTU

Genomics in Medicine

Master of Technology (M.Tech.) Bio-medical Engineering, 2013@DTU

Genomics and Proteomics (Theory and Lab)

Bachelor of Technology (B.Tech.) Biotech. 2013 @DTU

Genetic Engineering (Theory and Lab)

Bachelor of Technology (B.Tech.) Biotech.2012 @DTU

High throughput and structural Biology Lab

Master of Technology (M.Tech.) Biotech. 2012@DTU

Signal Transduction

Master of Science (M.Sc.) Biotech. 2012

Genetic Engineering

Master of Science (M.Sc.) Biotech. 2011

Medical Biotechnology

Master of Science (M.Sc.) Biotech 2011

Genetic Engineering

Master of Technology (M.Tech.) Biotech. 2010

Animal Biotechnology

Master of Technology (M.Tech.) Biotech. 2010

Medical Biotechnology

Master of Science (M.Sc.) BMG 2009

Medical Biotechnology

Master of Science (M.Sc.) Biotech.2010

Molecular Medicine

Bachelor of Technology (B.Tech.) Biotech.2009

Molecular Medicine

Bachelor of Technology (B.Tech.) Biotech.2010

Genomics and Proteomics

Bachelor of Technology (B.Tech.) Biotech.2009

Molecular Biology

Bachelor of Technology (B.Tech.) Biotech.2010

Recombinant DNA

Technology

Bachelor of Technology (B.Tech.) Biotech.2009

Cell Biology

Bachelor of Technology (B.Tech.) Biotech.2009

Medical Biotechnology

Bachelor of Technology (B.Tech.) Biotech.2009

B.Tech and M.Tech curriculum designer, developed different courses such as Signal Transduction, Molecular Medicine, Medical Biotechnology, Molecular Neurobiology, Genetic Engineering and many more.

MEMBERSHIPS

  1. Society for Neuroscience, Washington, USA
  2. Alzheimer forum, USA
  3. Indian Academic of Neurosciences, (India)-LK92 Life member
  4. Society for Biotechnologist (India)-L494, Life member
  5. Society for Neurochemistry (India); LM-I 265, Life member
  6. Asia Pacific Society for Neuroscience (APSN), 10-4-043-022.
  7. International Society for Neurochemistry (ISN)
  8. American Society of Neurochemistry (ASN)

PUBLICATIONS

Publications: ?Pravir Kumar - ?Google Scholar

Pravir Kumar - Search Results - PubMed (nih.gov)

PhD GUIDANCE AND PUBLICATIONS IN AGEING AND MOLECULAR NEUROSCIENCES-(PROTEOMICS AND METABOLOMICS)

  • Rahul Tripathi (2025): Deciphering mechanism of Alzheimer’s and Parkinson’s disease using network biology and functional genomics approach (PhD awarded, July 2025)
  • Mehar Sahu (2024) Proteinopathies, Proteotoxicity and Triaging In Neurodegenerative Disorders (PhD awarded, December 2024)
  • Neetu Rani (2024): Therapeutic Implications of Ubiquitin Proteasome System in Neurodegenerative Diseases (PhD awarded, December 2024)
  • Rohan Gupta (2023): Acetylation mechanism and HDAC’s enzymes in neurodegenerative diseases (Postdoc at University Medical School of South Carolina, USA)
  • Dhiraj Kumar (2019): Characterization, investigation and clearance mechanism of neurotoxic proteins in Alzheimer’s and Parkinson’s Disease (Postdoc fellow National Institute of Eye, NIH, Bethesda, USA)
  • Saurabh Kumar Jha (2017): Therapeutic action and signaling mechanism of biomolecules in neurodegenerative disorders (Assistant Professor at Kalindi College, Delhi University, India)
  • Niraj Kumar Jha (2017): Organs damage under hypoxic stress condition and their therapeutics approaches (Assistant Professor at Chitkara University, Chandigarh, India)
  • Renu Sharma (2017): Cyclin, HSPs and E3 ligase activity in cell cycle deregulation and neuro-muscular degeneration (Scientist at Pharma Company, Bengaluru, India)
  • Sonia Angeline (2013): Rotenone induced Parkinson’s disease model and differential expression of molecular chaperones- (Assistant Professor at Bengaluru University, India)
  • Aditi Sarkar (2013): Neuroprotective effect of bio molecules (Naringenin and Quercetin) under hypoxic stress conditions-2013 Director, in Genomics Company, Dubai
  • Shefali Kardam (2025): Thesis submission in progress

 

  1. Shefali Kardam, Pravir Kumar (2025) In Silico Identification of Natural SIRT1 Inhibitors through Molecular Docking, Dynamics Simulation, and MM/PBSA. Cell Biochemistry and Biophysics IF: 2.5 (Springer) [*: Corresponding author]. https://doi.org/10.1007/s12013-025-01886-0
  2. Somya Parashar, Aastha Kaushik, Rashmi Kumar Ambasta, Pravir Kumar (2025), E2 conjugating enzymes: A silent but crucial player in Ubiquitin Biology, Ageing Research Reviews, Volume 108, June 2025, 102740, IF: 12.4 (Elsevier) [*: Corresponding author] https://doi.org/10.1016/j.arr.2025.102740
  3. Ahmed Shaney Rehman, Ammar Tasleem, Nemat Ali, Rehan Khan, Mohd Salman, Pravir Kumar, Suhel Parvez (2025), Donepezil Improves PSD95 Expression, MitigatesNeuroinflammation via PI3K/Akt/NF-κB andMitochondrial Dysfunction in a Rodent Model ofSubarachnoid Haemorrhage, Journal of Neurochemistry, 2025; 169:e70063 1 of 22 IF: 4 (Wiely) https://doi.org/10.1111/jnc.70063
  4. Rahul Tripathi, Pravir Kumar (2025), Identification of CXCR4 inhibitory activity in natural compounds using cheminformatics-guided machine learning algorithms, (2025) Integrative Biology, Volume 17,zyaf004, IF: 2.5 (Oxford) [*: Corresponding author] https://doi.org/10.1093/intbio/zyaf004
  5. Neetu Rani, Pravir Kumar* (2025), Exploring Natural Compounds as Potential CDK4 Inhibitors for Therapeutic Intervention in Neurodegenerative Diseases Through Computational Analysis. IF: 2.6 Molecular Biotechnology (Springer), [*: Corresponding author] https://doi.org/10.1007/s12033-024-01258-8
  6. AS Rehman, Pravir Kumar, Suhel Parvez, (2025), Dopamine-D2-agonist targets mitochondrial dysfunction via diminishing Drp1 mediated fission and normalizing PGC1-α/SIRT3 pathways in a rodent model of Subarachnoid Haemorrhage, Neuroscience, Volume 564, Pages 60-78, 2025, IF: 2.9 https://doi.org/10.1016/j.neuroscience.2024.11.028
  7. Mehar Sahu, Rashmi K Ambasta, Suman R Das, Manoj K Mishra, Anil Shanker, Pravir Kumar (2024) Harnessing Brainwave Entrainment: A Non-invasive Strategy To Alleviate Neurological Disorder Symptoms, Ageing Research Reviews,Volume 101, (102547) 2024, IF: 12.4 (Elsevier) [*: Corresponding author] https://doi.org/10.1016/j.arr.2024.102547
  8. Shefali Kardam, Rashmi K Ambasta, Pravir Kumar*, (2024), Overview of pro-inflammatory and pro survival components in neuroinflammatory signalling and neurodegeneration, Volume 100, September 2024, 102465, Ageing Research Reviews, IF: 12.4 (Elsevier) [*: Corresponding author] https://doi.org/10.1016/j.arr.2024.102465
  9. Mehar Sahu, Neetu Rani, Pravir Kumar* (2024), Simulation and computational study of RING domain mutants of BRCA1 and Ube2k in AD/PD pathophysiology, IF: 2.6Molecular Biotechnology [*: Corresponding author]
  10. Shrutikirti Vashishth, Rashmi K Ambasta, Pravir Kumar*, (2024) Deciphering the Microbial Map and its implications in the therapeutics of Neurodegenerative Disorder, Volume 100, September 2024, 102466, Ageing Research Reviews, IF: 12.4 (Elsevier) [*: Corresponding author] https://doi.org/10.1016/j.arr.2024.102466
  11. Mehar Sahu, Shrutikirti Vashishth, Neha Kukreti, Ashima Gulia, Ashish Russell, Rashmi Kumar Ambasta, Pravir Kumar* (2024), Synergizing Drug Repurposing and Target Identification for Neurodegenerative Diseases Vol 205, Progress in Molecular Biology and Translational Science IF: 3.6 (Elsevier),, https://doi.org/10.1016/bs.pmbts.2024.03  [*: Corresponding author]
  12. Neetu Rani, Mehar Sahu, Rashmi K. Ambasta, Pravir Kumar* (2024), Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases, Ageing Research Reviews, IF: 12.4 (Elsevier) [*: Corresponding author]
  13. Rahul Tripathi, Pravir Kumar* (2023), Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer’s and Parkinson’s diseases Integrative Biology, Volume 15, 2023, zyad012, IF: 2.5 (Oxford) [*: Corresponding author] https://doi.org/10.1093/intbio/zyad012
  14. Aastha Kaushik, Somya Parasar, Rashmi Kumar Ambasta, Pravir Kumar* (2024) Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing Pathways in Neurodegenerative Disorders and Cancer, Volume 96, April 2024, 102279, Ageing Research Reviews, IF: 12.4 (Elsevier) https://doi.org/10.1016/j.arr.2024.102279 [*: Corresponding author]
  15. Neetu Rani, Aastha Kaushik, Shefali Kardam, Sonika Kag, V. Samuel Raj, Rashmi Kumar Ambasta, Pravir Kumar* (2024), Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases, Vol. 205, Progress in Molecular Biology and Translational Science IF: 3.6 (Elsevier), https://doi.org/10.1016/bs.pmbts.2024.03
  16. Rohan Gupta, Dia Advani, Divya Yadav, Rashmi K Ambasta, Pravir Kumar* (2023), Dissecting the relationship between neuropsychiatric and neurodegenerative disorders, Molecular Neurobiology. 60, 6476–6529 (2023); IF: 5.1 (Springer) [*: Corresponding author] DOI: 10.1007/s12035-023-03502-9.
  17. Rohan Gupta, Smita Kumari, Anusha Senapati, Rashmi K. Ambasta, Pravir Kumar* (2023), New era of Artificial intelligence and machine learning -based detection, diagnosis and therapeutics in Parkinson’s disease, Ageing Research Reviews, 90 (2023) 102013 IF: 12.4 (Elsevier) [*: Corresponding author] https://doi.org/10.1016/j.arr.2023.102013
  18. Rohan Gupta, Smita Kumari, Rahul Tripathi, Rashmi K. Ambasta, Pravir Kumar* (2023) Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases, Ageing Research Reviews, 86(2023)108155, IF: 12.4 (Elsevier), https://doi.org/10.1016/j.arr.2023.101855 [*: Corresponding author]
  19. Mehar Sahu, Rahul Tripathi, Niraj Kumar Jha, Saurabh Kumar Jha, Rashmi K Ambasta, Pravir Kumar (2022), Cross talk mechanism of disturbed sleep patterns in neurological and psychological disorders, Volume 140, September 2022, 104767 https://doi.org/10.1016/j.neubiorev.2022.104767 Neuroscience and Biobehavioural Reviews (Elsevier) IF: 8.2 (Elsevier), [*: Corresponding author]
  20. Divya Yadav and Pravir Kumar* (2022), Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics, Neurochemistry International, (Elsevier)  Volume 156, June 2022, 105327 IF: 4.2, https://doi.org/10.1016/j.neuint.2022.105327 [*: Corresponding author]
  21. Rohan Gupta, Mehar Sahu, Rahul Tripathi, Rashmi K. Ambasta, Pravir Kumar (2022) Protein S-sulfhydration: Unraveling the prospective of hydrogen sulfide in the brain, vasculature and neurological manifestations, Ageing Research Reviews, Volume 76, April 2022, 101579; IF: 12.4 (Elsevier), https://doi.org/10.1016/j.arr.2022.101579 [*: Corresponding author]
  22. Mehar Sahu, Rohan Gupta, Rashmi K. Ambasta, and Pravir Kumar* (2022), Artificial intelligence and machine learning in precision medicine: A paradigm shift in big data analysis,  2022;190(1):57-100 Progress in Molecular Biology and Translational Science, IF: 3.622 (Elsevier), https://doi.org/10.1016/bs.pmbts.2022.03.002, [*: Corresponding author]
  23. Rohan Gupta, Rashmi K Ambasta, Pravir Kumar* (2022), Multifaced role of protein deacetylase Sirtuins in Neurodegenerative disorders doi: 10.1016/j.neubiorev.2021.10.047 2022 Jan;132:976-997 Neuroscience and Biobehavioural Reviews (Elsevier) IF: 8.2 (Elsevier), [*: Corresponding author]
  24. Rohan Gupta, Pravir Kumar* (2022), Integrative analysis of OIP5-AS1/miR-129-5p/CREBBP axis as a potential therapeutic candidate in the pathogenesis of metal toxicity-induced Alzheimer’s disease, Gene Reports (Elsevier), Volume 26, March 2022, 101442, IF: 1.6 [*: Corresponding author]
  25. Rahul Tripathi, Rohan Gupta, Mehar Sahu, Devesh Srivastava, Ankita Das, Rashmi K Ambasta and Pravir Kumar* (2022) Free radical biology in neurological manifestations: mechanisms to therapeutics interventions, 2022 Sep;29(41):62160-62207 DOI: 10.1007/s11356-021-16693-2 Environmental Science and Pollution Research, (Springer), IF: 5.12 [*: Corresponding author]
  26. Sudhanshu Sharma, Dia Advani, Ankita Das, Nishtha Malhotra, Akanksha Khosla, Vanshika Arora, Ankita Jha, Megha Yadav, Rashmi K Ambasta, Pravir Kumar*, (2022) Pharmacological intervention in oxidative stress as a therapeutic target in neurological disorders, Volume 74, Issue 4, April 2022, Pages 461–484 https://doi.org/10.1093/jpp/rgab064; Journal of Pharmacy and Pharmacology (Oxford/Wiley), IF: 4.81 [*: Corresponding author]
  27. Rohan Gupta, Pravir Kumar* (2021), CREB1K292 and HINFPK330 as putative common therapeutic targets in Alzheimer’s and Parkinson’s disease, ACS Omega (ACS), (DOI: 10.1021/acsomega.1c05827), Dec 28; 6(51): 35780–35798. IF: 4.13 [*: Corresponding author]
  28. Rohan Gupta, Rashmi K Ambasta, Pravir Kumar* (2021), Autophagy and Apoptosis Cascade: Which is More Prominent in Neuronal Death? Cellular and Molecular Life Sciences (Springer) 78(24):8001-8047. doi: 10.1007/s00018-021-04004-410.1007/s00018-021-04004-4; (Unsolicited review) IF: 8.7 [*: Corresponding author]
  29. Rohan Gupta#, Ankita Jha#, Rashmi K Ambasta, Pravir Kumar* (2021), Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal Cell division, https://doi.org/10.1016/j.lfs.2021.120006; 285 (2021)120006, Life Sciences (Elsevier) IF: 6.1 [#: Equal contribution; *: Corresponding author]
  30. Vaibhav Oli, Rohan Gupta, Pravir Kumar (2021), FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders, Journal of Chemical Neuroanatomy, (Elsevier), 116 (2021) 102012 https://doi.org/10.1016/j.jchemneu.2021.102012 IF: 2.8 [*: Corresponding author]
  31. Rohan Gupta#, Mehar Sahu#, Devesh Srivastava#, Swati Tiwari#, Rashmi K Ambasta and Pravir Kumar* (2021), Post-translational modifications: Regulators of neurodegenerative proteinopathies, Volume 68, July 2021, 101336, https://doi.org/10.1016/j.arr.2021.101336 Ageing Research Review (Elsevier), IF: 12.5 2021 Jul;68:101336. doi: 10.1016/j.arr.2021.101336 [#: equal contribution; *: Corresponding author]
  32. Nishtha Malhotra, Rohan Gupta and Pravir Kumar* (2021), Pharmacological relevance of CDK Inhibitors in Alzheimer’s Disease, Neurochemistry International (Elsevier), Neurochemistry International 148 (2021) 105115 doi: 10.1016/j.neuint.2021.105115; IF: 4.297 [*: Corresponding author]
  33. Rohan Gupta, Rashmi K Ambasta, Pravir Kumar*, (2021) Histone Deacetylase enzymes in neuropathology, Advances in Clinical Chemistry (Elsevier); 104:151-231. doi: 10.1016/bs.acc.2020.09.004.; IF: 5. 4 [*: Corresponding author]
  34. Usman, M.B., Bhardwaj, S., Roychoudhury, S. et al. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives (2021) The Journal of Prevention of Alzheimer’s Disease (Springer) DOI: 10.14283/jpad.2021.52 IF: 6.4
  35. Rohan Gupta, Pravir Kumar* (2021), Computational analysis indicates that PARP1 acts as HDAC interactor sharing common lysine residues for acetylation, ubiquitination, and SUMOylation in Alzheimer's and Parkinson's disease (2021), ACS Omega (ACS), IF: 4.13 19;6(8):5739-5753 [Corresponding authors] [https://doi.org/10.1021/acsomega.0c06168]
  36. Harleen Kohli, Pravir Kumar*, Rashmi K. Ambasta (2021), In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease, Heliyon (Elsevier/Cell press), IF: 3.776 2021 Feb 12;7(2):e06088. doi: 10.1016/j.heliyon.2021.e06088 [Corresponding authors]
  37. Dhiraj Kumar, Rashmi K Ambasta, Pravir Kumar* (2020), Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies, DOI: 10.1016/j.arr.2020.101078, Ageing Research Review (Elsevier), IF: 12.4 [https://www.ncbi.nlm.nih.gov/pubmed/32407951]; [*: Corresponding author]
  38. Dia Advani, Rohan Gupta, Rahul Tripathi, Sudhanshu Shama, Rashmi K Ambasta, Pravir Kumar* (2020), Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach, Neurochemistry International (Elsevier), Volume 140, November 2020, 104841, https://doi.org/10.1016/j.neuint.2020.104841; IF: 4.2 [*: Corresponding author]
  39. Rohan Gupta, Rashmi K Ambasta, Pravir Kumar* (2020), Identification of novel Class I and Class IIb histone deacetylase inhibitor for Alzheimer’s disease therapeutics, 256, 1 September 2020, 117912, https://doi.org/10.1016/j.lfs.2020.117912 Life Sciences (Elsevier) IF: 6.1 [*: Corresponding author]
  40. Indu Bisth, Rashmi K Ambasta, Pravir Kumar*, (2020), An integrated approach to unravel a putative crosstalk network in Alzheimer’s disease and Parkinson’s disease, Neuropeptides (Elsevier), p.102078 [https://doi.org/10.1016/j.npep.2020.102078], IF: 2.8 [*: Corresponding author]
  41. Rohan Gupta, Rashmi K Ambasta, Pravir Kumar* (2020), Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders, Volume 243, 15 February 2020, 117278, https://www.ncbi.nlm.nih.gov/pubmed/31926248 Life Sciences (Elsevier) IF: 6.1 [*: Corresponding author]
  42. Rashmi K Ambasta, Krishna Adeshara, Shivangi Yadav, Pravir Kumar (2020), VEGF/CDK2 are involved in Diabetic organ regeneration, Biochemical and Biophysical Research Communications (Elsevier); 529, 1094-1100; https://doi.org/10.1016/j.bbrc.2020.07.014 IF: 3.1
  43. Swati Saran, Pravir Kumar, Rashmi K Ambasta, (2020), Discovery of novel compounds targeting DJ-1 as neuroprotectants for Parkinson’s disease by virtual screening and in silico method, Accepted, Current Computer-Aided Drug Design (Bentham; Clarivate indexed), IF: 1.606 [https://www.ncbi.nlm.nih.gov/pubmed/32303174]
  44. Arjun Sharma, Pravir Kumar, Ambasta RK. (2020), Cancer Fighting SiRNA-RRM2 loaded nanorobots, Pharmaceutical Nanotechnology (Bentham), doi: 10.2174/2211738508666200128120142 [https://www.ncbi.nlm.nih.gov/pubmed/32003677]
  45. Pooja Srivastava, Pravir Kumar and Anjani Tiwari (2020), Design, synthesis and in silico evaluation of methyl 2-(2-(5-bromo/chloro-2- oxobenzooxazol-3(2H)-yl)acetaamido-3-phenylpropanoate for TSPO targeting, Radiochemistry (Springer), 62(1):107 [https://link.springer.com/article/10.1134/S1066362220010142]
  46. Dhiraj Kumar and Pravir Kumar*(2019), Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides, Neuropeptide (Elsevier) 2019 Dec; 78:101971. https://www.ncbi.nlm.nih.gov/pubmed/31540705 doi: 10.1016/j.npep.2019.101971 IF: 3.286 [*: Corresponding author]
  47. Dhiraj Kumar, Pravir Kumar*(2019) An In-Silico Investigation of Key Lysine Residues and Their Selection for Clearing off Aβ and Holo-AβPP through Ubiquitination. Interdisciplinary Science: computational life science. December 2019, Volume 11, Issue 4, pp 584–596 doi: 10.1007/s12539-018-0307-2. IF: 3.492 (Springer) 30194628.https://www.ncbi.nlm.nih.gov/pubmed/30194628; [*: Corresponding author]
  48. Dhiraj Kumar and Pravir Kumar* (2019), Integrated mechanism of Lysine 351, PARK2 and STUB1 in AβPP ubiquitination, Journal of Alzheimers Disease (IOS) IF: 4.472 2019; 68(3):1125-1150. doi: 10.3233/JAD-181219 [ https://www.ncbi.nlm.nih.gov/pubmed/30958363]; [*: Corresponding author]
  49. Niraj Kumar Jha, Saurabh Kumar Jha, Renu Sharma, Dhiraj Kumar, Rashmi K Ambasta, Pravir Kumar*(2018), Hypoxia induced signaling activation in Neurodegenerative Diseases: Targets for new therapeutic strategies, Journal of Alzheimer’s Disease (IOS) 2018;62(1):15-38. IF: 4.472  doi: 10.3233/JAD-170589; https://www.ncbi.nlm.nih.gov/pubmed/29439330; [*: Corresponding author]
  50. Renu Sharma, Dhiraj Kumar, Niraj Kumar Jha, Saurabh Kumar Jha, Rashmi K. Ambasta, Pravir Kumar*(2017), Re-expression of cell cycle markers in aged neurons and muscles: whether cell should divide or die? Biochimica et Biophysica Acta, (BBA Molecular Basis of disease; Biochim Biophys Acta. 2017 Jan;1863(1):324-336 (Elsevier); invited manuscript; IF: 6.633, [http://www.ncbi.nlm.nih.gov/pubmed/27639832] [*: Corresponding author]
  51. Saurabh Kumar Jha, Niraj Kumar Jha, Dhiraj Kumar, Renu Sharma, Abhishek Srivastava, Rashmi K. Ambasta, Pravir Kumar*(2017), “Stress-induced synaptic dysfunction and neurotransmitter release in Alzheimer's disease: Can neurotransmitter and Neuromodulator be potential therapeutic targets?” 2017;57(4):1017-1039, (invited manuscript; Journal of Alzheimer’s Disease (IOS) Impact factor: 4.472 [*: Corresponding author]
  52. Saurabh Kumar Jha, Niraj Kumar Jha, Dhiraj Kumar, Rashmi K. Ambasta, Pravir Kumar*(2017), Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration, Biochimica et Biophysica Acta, BBA Molecular Basis of disease; (Invited manuscript; Special issue: Oxidative Stress and Mitochondrial Quality in Diabetes/Obesity and Critical Illness Spectrum of Diseases) May;1863(5):1132-1146.; (Elsevier) IF: 6.633 [http://www.ncbi.nlm.nih.gov/pubmed/27345267] [*: Corresponding author]
  53. Niraj Kumar Jha and Pravir Kumar*(2017), Biomolecules mediated targeting of Vascular Endothelial Growth Factor in neuronal dysfunction: An in silico approach, Asian Journal Pharmacy and Clinical Research, Article in press, Vol.10 September Issue [*: Corresponding author]
  54. Niraj Kumar Jha and Pravir Kumar*(2017), “Molecular docking studies for the comparative analysis of different biomolecules to target Hypoxia inducible factor-1α", International Journal of Applied Pharmaceutics, Article in press, Vol 9 Issue 4, July 2017. [*: Corresponding author]
  55. Renu Sharma, Pravir Kumar*(2017), Neuroprotective role of bimoclomol in ectopic cell cycle in Parkinson’s disease: new insights, Asian Journal Pharmacy and Clinical Research, Vol 10, Issue 6, 2017, 1-4 [*: Corresponding author]
  56. Renu Sharma, Pravir Kumar*(2017), Repurposing HSP70 Inducing Compounds for Targeting Post-Mitotic Cell Division: Novel Promises as Neuroprotectants; J. Chem. Pharm. Res., 2017, 9(3):373-384 [*: Corresponding author] 
  57. Saurabh Kumar Jha, Pravir Kumar*(2017), An in silico study of Naringenin mediated neuroprotection in Parkinson’s disease, Asian Journal Pharmacy and Clinical Research, Vol 10, Accepted [*: Corresponding author]
  58. Saurabh Kumar Jha, Pravir Kumar*(2017), Molecular docking study of neuroprotective plant-derived biomolecules in Parkinson’s disease, International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 9 (9), 2017 [*: Corresponding author]
  59. Pooja Srivastava, Ankur Kaul, Himanshu Ojha, Pravir Kumar, Anjani K Tiwari (2016), Design, synthesis and biological evaluation of methyl-2-(2-(5-bromo benzoxa-zolone)acetamido)-3-(1H-indol-3-yl)propanoate: TSPO ligand for SPECT,  RSC Advances, 2016, 6, 114491-114499; IF: 4.036 http://pubs.rsc.org/en/content/articlelanding/2016/ra/c6ra19514h#!divAbstract
  60. Saurabh Kumar Jha, Niraj Kumar Jha, Pravir Kumar and Rashmi K Ambasta (2016), Molecular Chaperones and Ubiquitin Proteasome System in Tumor Biogenesis: An Overview, Journal of Cell Biology and Cell Metabolism, 3: 010
  61. Pravir Kumar*, Dhiraj Kumar, Saurabh Kumar Jha, Niraj Kumar Jha, Rashmi K Ambasta (2016), “Ion channels in neurological disorders” 2016;103:97-136 (Invited manuscript). Advances in Protein Chemistry and Structural Biology, IF: 3.507  http://www.ncbi.nlm.nih.gov/pubmed/26920688] [*: Corresponding author]
  62. Niraj Kumar Jha, Saurabh Kumar Jha, Dhiraj Kumar, Noopur Kejariwal, Renu Sharma, Rashmi K Ambasta and Pravir Kumar*(2015), Impact of IDE and Neprilysin in Alzheimer's Disease biology: Characterization of putative coagnates for therapeutic applications. Journal of Alzheimer’s Disease 2015, 48(4):891-917; IF: 4.472; http://www.ncbi.nlm.nih.gov/pubmed/26444774] [*: Corresponding author]
  63. Pravir Kumar*, Niraj Kumar Jha, Saurabh Kumar Jha, Karunya Ramani and Rashmi K Ambasta (2015), Tau phosphorylation, molecular chaperones, Ubiquitin E3 ligase: clinical relevance in Alzheimer’s disease, 2015;43(2):341-61; Journal of Alzheimer’s Disease, IF: 4.472 [*: Corresponding author] [http://www.ncbi.nlm.nih.gov/pubmed/25096626]
  64. Rajat Gupta, Piyush Sawhney, Rashmi K Ambasta and Pravir Kumar*(2015), Obesity and Neurodegeneration, Advances in Obesity, Weight Management & Control (AOWMC), 2 (5), 029 [*: Corresponding author]
  65. Saurabh Kumar Jha, Niraj Kumar Jha, Rohan Kar, Rashmi K Ambasta, Pravir Kumar*(2015), p38 MAPK and PI3K/AKT signaling in Parkinson’s disease, International Journal of Molecular and Cellular Medicine (IJMCM), Spring 2015, Vol 4, No 2, page 1-20 [*: Corresponding author]
  66. Arivarasan A., Soni Krishna, Shivangi Yadav, Harshit Rajesh Shah, Pravir kumar, Rashmi Kumar Ambasta (2015), Synergy of bone marrow transplantation and curcumin ensue protective effect at early onset of diabetes in mice, Jul;7(4):473-84, Journal of Diabetes, (Wiley) IF: 4.530 [http://www.ncbi.nlm.nih.gov/pubmed/25060836] [Key article in Global Medical Discovery]
  67. Dhiraj Kumar, Sakshi Sharma, Sagar Verma, Pravir Kumar and Rashmi Kumar Ambasta (2015), Role Of wnt-p53-Nox Signaling Pathway In Cancer Development And Progression, British Journal of Medicine and Medical Research, 8(8):651-676; 2015 ISSN: 2231-061
  68. Dhiraj Kumar, Sakshi Sharma, Sagar Verma, Pravir Kumar and Rashmi Kumar Ambasta (2015), Molecular signaling saga in tumour biology, Journal of Tumor (ISSN 1819-6187), 18, 3(2):309-313
  69. Dhiraj Kumar, Rashmi K Ambasta and Pravir Kumar*(2014), Mutational consequences of aberrant ion channels in neurological disorders, Nov;247(11):1083-127., The Journal of Membrane Biology (Springer), IF: 2.47 [http://www.ncbi.nlm.nih.gov/pubmed/25119057] [*: Corresponding author]
  70. Niraj Kumar Jha, Saurabh Kumar Jha, Rohan Kar, Rashmi K Ambasta and Pravir Kumar*(2014), Role of oxidative stress, ER stress and Ubiquitin Proteasome system in neurodegeneration, 07/2014; 01(2).1-10; MOJ Cell Science and Report. [http://medcraveonline.com/MOJCSR/MOJCSR-01-00010.pdf]
  71. Bumsup Kwon*, Pravir Kumar*, Hank-Kyu Lee, Ling Zeng, Kenneth Walsh, Qinghao Fu, Amey Barakat and Henry W Querfurth (2014), Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis, Human Molecular Genetics Jul 15;23(14):3681-94. Impact factor: 6.150 (*Joint first authors); [http://www.ncbi.nlm.nih.gov/pubmed/24556217]
  72. Krishna Soni, Anuja Lipsa, Rohan Kar, P. B. Sharma, Pravir Kumar, Rashmi K. Ambasta (2014) Stem cell: transition from basics to advanced technology. American Journal of Research Communication, [http://www.usa-journals.com/wp-content/uploads/2014/03/Soni_Vol23.pdf]
  73. Sonia Angeline, Aditi Sarkar, Kushi Anand, Rashmi K Ambasta and Pravir Kumar*(2013), Sesamol and naringenin reverse the effect of rotenone induced PD rat model, Volume 254,19 December 2013, Pages 379-394* - Neuroscience, IF: 3.708, [http://www.ncbi.nlm.nih.gov/pubmed/24070629] [Key article in Global Medical Discovery] [*: Corresponding author]
  74. Pravir Kumar*, Rohan Kar, P.B. Sharma and Rashmi K. Ambasta (2013), Collaborative action of Cell cycle, molecular chaperones and Ubiquitin proteasome system in Neurooncology, Journal of Protein and Proteomics, 4(1), pp 35-43 Impact factor: 0.46 [http://jpp.org.in/index.php/jpp/article/view/6]; [*: Corresponding author]
  75. Pravir Kumar*, Irshad Gandhi, P.B. Sharma and Rashmi K. Ambasta (2013), Why our heart is not prone to cancer? American Journal of Research Communication, 1 (7), 143-151 [www.usa-journals.com/wp-content/uploads/2013/06/Kumar_Vol17.pdf] [*: Corresponding author]
  76. Aditi Sarkar, Sonia Angeline, Kushi Anand, Rashmi K Ambasta and Pravir Kumar*, (2012), Neuroprotective effect of flavanoids in hypobaric hypoxia in murine model, Brain Research; Oct 24;1481:59-70; IF: 3.61 [http://www.ncbi.nlm.nih.gov/pubmed/22981402] [*: Corresponding author]
  77. Sonia Angeline, Priya Chatterjee, Kushi Anand, Rashmi K Ambasta and Pravir Kumar*, (2012) “Rotenone induced Parkinsonism elicit the behavioral impairment along with differential expression of Parkin, heat shock proteins and caspase in rat, Neuroscience, 220; 291–301; IF: 3.78 [http://www.ncbi.nlm.nih.gov/pubmed/22710069] [*: Corresponding author]
  78. A. Arivarasan, Gaurav Rana, Archita Sharma, Manish Kumar, Karishma Jhang, Arundhati Chakraborty, Pravir Kumar, Rashmi K Ambasta (2012), Clinical management of lipid profile, renal and liver function versus HbA1c profile in diabetes affected patients of Vellore, Tamil Nadu, India, African Journal of Pharmacy and pharmacology 6 (40), 2832-2836 Impact factor: 0.839) [http://www.academicjournals.org/article/article1380892597_Arivarasan%20et%20al.pdf]
  79. Pravir Kumar*, Kaveri Pradhan, R. Karunya, Rashmi K Ambasta and Henry W. Querfurth (2012), Cross functional E3 ligase CHIP and Parkin in neurological disorders, Journal of Neurochemistry, INVITED REVIEW to PRAVIR KUMAR; Feb; 120(3):350-70Nov 20. IF: 5. 546; [http://www.ncbi.nlm.nih.gov/pubmed/22098618] [*: Corresponding author]
  80. Pravir Kumar*, Shalini Pal and Rashmi Ambasta (2011), Nicotine therapy: whether a good or bad move in Parkinsonism in concert with HSPs? (* - Corresponding author; Journal of Pharmacy Research, 4(10), 3514-3519 [http://connection.ebscohost.com/c/articles/74697502/nicotine-therapy-whether-good-bad-move-parkinsonism-concert-hsps]
  81. Harshit Shah, Arivarsan A, Pravir Kumar and Rashmi K Ambasta, (2011), Protective effect of bone marrow transplantation in organ damage due to diabetes African Journal of Pharmacy and pharmacology, Vol.5 (23), pp2605-2612, December; Impact factor: 0.839
  82. Rashmi K. Ambasta, Ira Dave, Pravir Kumar (2011); PTEN- Somatic mutations causing cancer: Cancer Genome Sequence Analysis Journal of Pharmacy Research, 4(10), 3568-3574
  83. Harshit Shah, Pravir Kumar and Rashmi K Ambasta*, (2011) Mesenchymal stem cells: an Overview, Journal of Pharmacy Research, 4(10), 3556-3558
  84. Rosen KM*, Moussa C.E.-H. *, Lee H-K *, Pravir Kumar *, Kitada T, Qin G, Fu Q, Querfurth HW (2010), Parkin Reverses Intracellular β-Amyloid Accumulation and Its Negative Effects on Proteasome Function, Journal of Neuroscience Research; *equal first author contribution 88:167-78 Impact factor: 4.164 [http://www.ncbi.nlm.nih.gov/pubmed/19610108]
  85. Lee H-K, Pravir Kumar, Fu Q, Rosen KM, Querfurth HW. (2009), The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid, Molecular Biology of Cell 20:1533-44 Impact factor: 5.8 [http://www.ncbi.nlm.nih.gov/pubmed/19144826]
  86. Pravir Kumar, Ambasta RK, Veereshwarayya V, Rosen KM, Patterson C, Kosik KS, Band H, Mestril R, Querfurth HW (2007), CHIP and HSPs interact with β-APP in a proteasome-dependent manner and influence Aβ metabolism. Human Molecular Genetics Impact factor: 8.1 16:848-64. Impact factor: 6.150 [http://www.ncbi.nlm.nih.gov/pubmed/17317785]
  87. Querfurth HW, Rosen KR, Moussa CE, Pravir Kumar, (2007), Cross functional E3 ligases Parkin and CHIP in Alzheimer’s and Parkinson’s disease proteinopathy, volume 62, Issue suppl 11, page S3-S16, October, Annals of Neurology, Impact factor: 11.274 [http://onlinelibrary.wiley.com/doi/10.1002/ana.11639/abstract]
  88. Moussa C, Fu Q, Pravir Kumar, Shtifman A, Lopez J-R, Allen PD, LaFerla F, Weinberg D, Magrane J, Aprahamian T, Walsh K, Rosen KM, Querfurth HW (2006), Transgenic expression of Beta-APP in fast twich muscle leads to calcium dyshomeostasis and IBM like pathology. FASEB Journal 20:2165-7. Impact factor: 6.4  [http://www.ncbi.nlm.nih.gov/pubmed/16940437]
  89. Veereshwarayya V, Pravir Kumar, Rosen KM, Mestril R, Querfurth HW (2006), Differential effects of mitochondrial Hsp60 and related molecular chaperones to prevent → -amyloid – induced inhibition of complex IV and limit apoptosis. Journal of Biological Chemistry 281:29468-78. Impact factor: 5.486 [http://www.ncbi.nlm.nih.gov/pubmed/16887805]
  90. Ambasta RK, Pravir Kumar, Schmidt HHW, Busse R, Brandes RP (2004), Direct interaction of the novel Nox proteins with p22phox for the formation of a functionally active NADPH oxidase, Journal of Biological Chemistry 279:45935-45941 Impact factor: 5.486 [http://www.ncbi.nlm.nih.gov/pubmed/15322091]

PhD GUIDANCE AND PUBLICATIONS IN CANCER BIOLOGY:

PhD students trained in single supervision:

  • Smita Kumari (2023): Modulating tumor microenvironment using combinatorial therapy, Postdoc at Ohio state university, USA)
  • Dia Advani (2023): Intrinsic mechanism of anti-cancer drugs in neurodegenerative disorders, (Postdoc at Khalifa University, Dubai)
  • Sudhanshu Sharma (2023): Collaborative action of molecular chaperones, ubiquitin E3 ligase and signalling molecules in the reversal of glioblastoma and other brain tumors (Postdoc at Alabama state University, USA)
  • Kushi Anand (2013): Characterization and screening of biomolecules for cancer therapy -DBT Welcome early fellow at NCBS/IISc, Bengaluru, India; Associate Professor at K. J. College)
  1. Smita Kumari, Pravir Kumar* (2023), Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment, Frontiers in Cell and Developmental Biology; IF: 4.6 Volume 11 - 2023 | doi: 10.3389/fcell.2023.1236271 [*: Corresponding author]
  2. Smita Kumari, Pravir Kumar* (2023), Designing and computational analysis of MMP9 inhibitor in hypoxia induced Glioblastoma multiforme, ACS Omega (ACS), 2023, 8, 11, 10565–10590 2023 IF: 3.7 [*: Corresponding author]
  3. Smita Kumari, Rohan Gupta, Rashmi Kumar Ambasta, Pravir Kumar* (2023), Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy, Biochimica et Biophysica Acta, (BBA) Review on Cancer 1878(4):188913. (Elsevier), IF: 9.7 BBA- Reviews on Cancer (Elsevier) https://doi.org/10.1016/j.bbcan.2023.188913 [*: Corresponding author]
  4. Sudhanshu Sharma, Pravir Kumar*(2023), HSP90AB1 and other heat shock proteins in countering glioblastomas and ependymomas using omics analysis and drug prediction using virtual screening, Neuropeptides (Elsevier) Volume 102, December 2023, 102383 (https://doi.org/10.1016/j.npep.2023.102383) IF: 2.5  [*: Corresponding author]
  5. Sudhanshu Sharma, Pravir Kumar* (2023), Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma, ACS Omega (ACS), (DOI: 10.1021/acsomega.1c05827), 2023, 8, 5, 5072–5087. IF: 3.7 [*: Corresponding author]
  6. Smita Kumari, Sudhanshu Sharma, Dia Advani, Akanksha Khosla, Pravir Kumar, Rashmi K Ambasta (2022), Unboxing the molecular modalities of mutagens in cancer, 2022 Sep;29(41):62111-62159 DOI:10.1007/s11356-021-16726-w Environmental Science and Pollution Research, (Springer), IF: 5.12
  7. Smita Kumari, Dia Advani, Sudhanshu Sharma, Rashmi K Ambasta and Pravir Kumar* (2021), Combinatorial Therapy in Tumor microenvironment: Where do we stand? Accepted June 24, 2021, Biochimica et Biophysica Acta, (BBA) Review on Cancer (Elsevier), IF: 9.7 Jul 2;1876(2):188585. doi: 10.1016/j.bbcan.2021.188585. [*: Corresponding author]
  8. Smita Kumari, Rohan Gupta, Rashmi Kumar Ambasta, Pravir Kumar* (2023),Emerging trends in post translational modification: shedding light on Glioblastoma multiforme, Accepted  Biochimica et Biophysica Acta (Elsevier), Volume 1878, Issue 6, November 2023, 188999 IF: 9.7 BBA- Reviews on Cancer[*: Corresponding author]
  9. Dia Advani, Pravir Kumar (2022), Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach, Neuropeptides (Elsevier) Volume 96,  December 2022, 102283 (https://doi.org/10.1016/j.npep.2022.102283 IF: 2.9  [*: Corresponding author]
  10. Dia Advani, Pravir Kumar* (2021), Therapeutic targeting of repurposed anticancer drugs in Alzheimer’s Disease: using multi-omics approach, 19;6(21):13870-13887. doi: 10.1021/acsomega.1c01526. ACS Omega (ACS), IF: 3.7 [*: Corresponding author]
  11. Dia Advani, Pravir Kumar* (2024), Uncovering cell cycle dysregulations and associated mechanisms in cancer and neurodegenerative disorders: A glimpse of hope for repurposed drugs, Molecular Neurobiology. IF: 5.1 (Springer) [*: Corresponding author] https://doi.org/10.1007/s12035-024-04130,
  12. Dia Advani, Sudhanshu Sharma, Smita Kumari, Rashmi K Ambasta, Pravir Kumar* (2021), Precision oncology, signaling and anticancer agents in cancer therapeutics, Anti-cancer agents in Medicinal Chemistry (Bentham), IF: 2.505 Mar 7. doi: 10.2174/1871520621666210308101029. [Corresponding authors]
  13. Ambasta RK, Gupta R, Kumar D, Bhattacharya S, Sarkar A, Pravir Kumar. (2019) Can luteolin be a therapeutic molecule for both colon cancer and diabetes? Briefing in Functional Genomics (Oxford) Volume 18, Issue 4, July 2019, Pages 230–239 [https://www.ncbi.nlm.nih.gov/pubmed/30462152] IF: 3.4
  14. Rashmi K Ambasta, Harleen Kohli, Pravir Kumar (2017), Multiple Therapeutic Effect of Endothelial Progenitor Cell regulated by drugs in Diabetes and Diabetes related disorder, in press, August 2017, Journal of Translational Medicine, (Springer)Aug 31;15(1):185. doi: 10.1186/s12967-017-1280-y. IF: 6.1 https://www.ncbi.nlm.nih.gov/pubmed/28859673
  15. Rashmi K. Ambasta, Saurabh Kumar Jha, Dhiraj Kumar, Renu Sharma, Niraj Kumar Jha, and Pravir Kumar (2015) Comparative study of anti-angiogenic activities of luteolin, lectin and lupeol biomolecules, September 2015, 18;13:307, Journal of Translational Medicine, (Springer) Impact factor: 6.1 [http://www.ncbi.nlm.nih.gov/pubmed/26385094]
  16. Kushi Anand, Aditi Sarkar, Anup Kumar, Rashmi K Ambasta and Pravir Kumar*(2012) Combinatorial anti-tumor effect of Naringenin and Curcumin elicit angio-inhibitory activity in vivo, Nutrition and Cancer, Vol. 64, issue 5 IF: 2.86; [http://www.ncbi.nlm.nih.gov/pubmed/22642894] [*: Corresponding author]
  17. Kushi Anand, Pallavi Asthana, Anup Kumar, Rashmi K Ambasta and Pravir Kumar*(2012), Quercetin mediated reduction of angiogenic markers and chaperones in DLA induced solid tumours; Asian Pacific Journal of Cancer Prevention, 12, 2829-2835; IF: 2.26 [http://www.ncbi.nlm.nih.gov/pubmed/22393949] [*: Corresponding author]
  18. Pratik Chakraborty; Sabya Sachi Das; Abhijit Dey; Apala Chakraborty; Chiranjib Bhattacharyya; Ramesh Kandimalla; Biswajit Mukherjee, Ph.D; Abilash Valsala Gopalakrishnan; Sandeep Kumar Singh, Ph.D; Shubham Kant; Parma Nand; Shreesh Ojha, Ph.D; Pravir Kumar, Ph.D; Niraj Kumar Jha; Saikat Dewanjee (2022), Quantum Dots: the Cutting-Edge Nanotheranostics in Brain Cancer Management, Volume 350, October 2022, Pages 698-715 Journal of Controlled Release (Elsevier) IF: 10.8
  19. Rashmi K. Ambasta, Archita Sharma, Pravir Kumar (2011), Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy Vascular Cell 2011, 3:26 (BMC journal). [http://www.ncbi.nlm.nih.gov/pubmed/22082307]

PhD GUIDANCE AND PUBLICATIONS IN BIOCHEMISTRY AND

MEDICINAL CHEMISTRY

Sonika Kag* (2024): Sustainable production of industrially important chemicals from Agro-industrial (* co-supervision)

Neha Kukreti* (2024): Implementation of stubble waste for biotransformation to industrially important chemicals (* co-supervision)

Pooja Shrivastava* (2019): Design, synthesis and characterization of novel heterocyclic ligands for biomedical imaging (Scientist E at Institute of Nuclear Medicine and Sciences, INMAS, Delhi, India)

  1. Neha Kukreti, Pravir Kumar, Rashmi Kataria (2024), Conversion of corn stover for microbial enzymes production by Phanerochaete chrysosporium" IF: 3.0 Applied Biochemistry and Biotechnology (Springer) https://doi.org/10.1007/s12010-023-04811-4
  2. Neha Kukreti, Pravir Kumar, R Kataria (2024) A sustainable synthesis of polyhydroxyalkanoate from stubble waste as a carbon source by using Pseudomonas putida MTCC 2475 IF: 5.7 Frontiers in Bioengineering and Biotechnology Sec. Industrial Biotechnology (Frontiers)
  3. Neha Kukreti, Pravir Kumar, R Kataria (2024) Sustainable biotransformation of lignocellulosic biomass to microbial enzymes: An overview and update Volume 222, Part 1, 15 December 2024, 119432 IF: 5.6; Industrial Crops & Products (Elsevier); https://doi.org/10.1016/j.indcrop.2024.119432
  4. Sonika Kag, Pravir Kumar, Rashmi Kataria, (2024), Acid hydrolysis of solanum tuberosum periderm in accumulation of polyhydroxyalkonates in Pseudomonas putida MTCC 2475, Volume 12 - 2024; doi: 10.3389/fbioe.2024.1343540 IF: 5.7 Frontiers in Bioengineering and Biotechnology Sec. Industrial Biotechnology (Frontiers)
  5. Hediyal TC et al., (2024) “Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: An Update"2024 Feb 21:15:1324018. doi: 10.3389/fimmu.2024.1324018 IF: 7.3 Frontiers in Immunology, section Microbial Immunology
  6. Khyati Joshi, Pravir Kumar, Rashmi Kataria (2023), Microbial carotenoid production and their potential applications as antioxidants: A current update, Process Biochemistry (Elsevier), https://doi.org/10.1016/j.procbio.2023.0; 128, (2023),190-205 IF: 4.4
  7. Sonika Kag, Pravir Kumar, Rashmi Kataria (2023), Potato Peel Waste as an Economic Feedstock for PHA Production by Bacillus circulans. Applied Biochemistry and Biotechnology (2023). https://doi.org/10.1007/s12010-023-04741-1, IF: 3.0
  8. Neha Kukreti, Sonika Kag, Pravir Kumar, Rashmi Kataria (2023), Potential of waste stream in conversion into sustainable metabolites: An overview and update, Bioresource Technology Reports (Elsevier), Volume 22,101502 https://doi.org/10.1016/j.biteb.2023.101502
  9. Shanu Bhardwaj, Kavindra Kumar Kesari, Mahesh Rachamalla, Shalini Mani, Ghulam Md Ashraf, Saurabh Kumar Jha, Pravir Kumar, Rashmi K Ambasta, Harish Dureja, Hari Prasad Devkota, Gaurav Gupta, Dinesh Kumar Chellappan, Sachin Kumar Singh, Kamal Dua, Janne Ruokolainen, Mohammad Amjad Kamal, Shreesh Ojha, Niraj Kumar Jha, (2021) CRISPR-Cas9 gene editing: New hope for Alzheimer's disease therapeutics, SI: Trends in Management of Dementia and Frailty, 2022 Sep;40:207-221 Journal of Advanced Research, (Elsevier), https://doi.org/10.1016/j.jare.2021.07.001, IF: 10.7
  10. Pooja Srivastava, Pravir Kumar and Anjani Tiwari (2019), Modified benzoxazolone (ABO-AA) based SPECT probes for 18 kDa TSPO Article Drug Development and Research Sep; 80(6):741-749. doi: 10.1002/ddr.21547. (Wiley) IF: 5.004 [https://www.ncbi.nlm.nih.gov/pubmed/31184784]
  11. Pooja Srivastava, Neelam Kumari, Dipti Kakkar, Ankur Kaul, Pravir Kumar and Anjani K Tiwari (2019) Comparative evaluation of 99mTc-MBIP-X/11[C] MBMP for visualization of 18 kDa translocator protein, Manuscript New Journal of Chemistry, https://doi.org/10.1039/C9NJ00180H IF: 3. 925 (RSC)
  12. Chauhan S, Manivasagam G, Pravir Kumar, Ambasta RK. (2018), Cellular Toxicity of Mesoporous Silica Nanoparticle in SHSY5Y and BM-MNCs Cell. Pharmaceutical Nanotechnology 6(4):245-252. [https://www.ncbi.nlm.nih.gov/pubmed/30381088]
  13. Bharti K, V. Koskull-Döring P, Bharti S, Pravir Kumar, Tintschl- Körbitzer A, Treuter E, Nover L (2004), Tomato heat stress transcription factor HsfB1 represents a novel type of general transcription coactivator with a histone-like motif interacting with HAC1/CBP. Plant Cell 16:1521-35; Impact factor: 11.277[http://www.ncbi.nlm.nih.gov/pubmed/15131252]

PUBLICATIONS IN AI/ML AND BIG DATA

  1. Mehar Sahu, Rohan Gupta, Rashmi K Ambasta, Pravir Kumar* (2024), IoT-driven Augmented Reality and Virtual Reality Systems in Neurological Sciences, Volume 25, April 2024, 101098; IF: 6.0 Internet of Things (Elsevier) https://doi.org/10.1016/j.iot.2024.101098
  2. Mehar Sahu, Rohan Gupta, Rashmi K. Ambasta, and Pravir Kumar* (2022), Artificial intelligence and machine learning in precision medicine: A paradigm shift in big data analysis,  2022;190(1):57-100 Progress in Molecular Biology and Translational Science, IF: 3.622 (Elsevier), https://doi.org/10.1016/bs.pmbts.2022.03.002, [*: Corresponding author]
  3. Rohan Gupta#, Devesh Srivastava#, Mehar Sahu#, Swati Tiwari#, Rashmi K Ambasta and Pravir Kumar*(2021), Deep learning approach: an excellent and modernised tool for drug discovery, Molecular Diversity, 25(3), 1315-1360 10.1007/s11030-021-10217-3, (Springer), IF: 3.3 [#: equal contribution; *: Corresponding author]

 

PEER-REVIEWED CONFERENCE PUBLICATIONS-IEEE FULL LENGTH CONFERENCE PAPERS (Pravir Kumar - IEEE Xplore Author Profile)

  1. R. Mrinal and P. Kumar, "Integrating Machine Learning and Gene Expression Analysis for Dementia Subtype Classification and Biomarker Discovery," 2025 International Conference on Advances in Modern Age Technologies for Health and Engineering Science (AMATHE), Shivamogga, India, 2025, pp. 1-6, doi: 10.1109/AMATHE65477.2025.11081300.

  2. H. Vardhan and P. Kumar, "In silico analysis of deleterious p53 SNPs in Parkinson’s Disease," 2025 International Conference on Ambient Intelligence in Health Care (ICAIHC), Raipur Chattisgarh, India, 2025, pp. 1-5, doi: 10.1109/ICAIHC64101.2025.10957514.
  3. P. Kaur and P. Kumar, "Bioinformatics-Guided Drug Repurposing for Precision Management of Parkinson’s Disease: Targeting the LRRK2 G2019S," 2024 International Conference on Communication, Computing and Energy Efficient Technologies (I3CEET), Gautam Buddha Nagar, India, 2024, pp. 34-39, doi: 10.1109/I3CEET61722.2024.10993568.
  4. R. Mrinal and P. Kumar, "In Silico Identification of Novel GABRA2 Inhibitors Leveraging the Power of Virtual Screening," 2024 IEEE 11th Uttar Pradesh Section International Conference on Electrical, Electronics and Computer Engineering (UPCON), Lucknow, India, 2024, pp. 1-6, doi: 10.1109/UPCON62832.2024.10983394.
  5. Apurva and P. Kumar, "In silico Analysis for Potential SIRT2 Inhibitors," 2024 2nd International Conference on Advances in Computation, Communication and Information Technology (ICAICCIT), Faridabad, India, 2024, pp. 474-479, doi: 10.1109/ICAICCIT64383.2024.10912162.
  6. S. Verma and P. Kumar, "Computational Approach for Prediction of NMDA antagonist in Huntingtin’s Disease," 2024 OPJU International Technology Conference (OTCON) on Smart Computing for Innovation and Advancement in Industry 4.0, Raigarh, India, 2024, pp. 1-6, doi: 10.1109/OTCON60325.2024.10688037.
  7. Ashima Gulia and Pravir Kumar, "Comparative Docking Strategies for Alzheimer’s Therapy: Exploring Drug and Phytocompound Interactions with BIN1 Protein," 2024 4th International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE), Greater Noida, India, 2024, pp. 1895-1899, doi: 10.1109/ICACITE60783.2024.10617309.
  8. Shikha Kadyan and Pravir Kumar, "Analyzing speech patterns for Parkinson’s diagnosis: Insights from ML models," 2024 4th International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE), Greater Noida, India, 2024, pp. 1904-1909, doi: 10.1109/ICACITE60783.2024.10617205.
  9. Pallavi and Pravir Kumar, "Employing Multifaceted Bioinformatics Strategies for the Discovery of Novel ASK1 Inhibitors Targeting Neurodegenerative Disorders," 2024 International Conference on Knowledge Engineering and Communication Systems (ICKECS), Chikkaballapur, India, 2024, pp. 1-5, doi: 10.1109/ICKECS61492.2024.10616397.
  10. Ashish and Pravir Kumar, "Pharmacoinformatic-guided Drug Reprofiling for Unveiling of NovelBioactive Inhibitors Targeting USP13 in the Treatment of Parkinson’s Disease," 2024 International Conference on Knowledge Engineering and Communication Systems (ICKECS), Chikkaballapur, India, 2024, pp. 1-5, doi: 10.1109/ICKECS61492.2024.10616774.
  11. Anjali Roy and Pravir Kumar, "Unravelling Parkinson’s Disease Therapeutics: Computational Insights into VPS35 via Drug Repurposing," 2024 International Conference on Knowledge Engineering and Communication Systems (ICKECS), Chikkaballapur, India, 2024, pp. 1-5, doi: 10.1109/ICKECS61492.2024.10616510.
  12. Anistha, Pravir Kumar, Revolutionizing Glioblastoma Treatment: In Silico Discovery Targets SOX2 Gene through Molecular Docking, Unveiling Potential of Cosmegen and Repurposed Penfluridol, 2024 International Conference on Automation and Computation (AUTOCOM) 197-201, doi: 10.1109/AUTOCOM60220.2024.10486129.
  13. Aastha Kaushik, Pravir Kumar In-Silico Structural Analysis of Membrane-Associated RING-CH Type 2 (MARCH 2) Protein 2023 International Conference on Integration of Computational Intelligent System (ICICIS) pp. 1-6, doi: 10.1109/ICICIS56802.2023.10430285
  14. Aastha Kaushik, Pravir Kumar In-Silico Analysis for Differentially Expressed Genes in Multiple Sclerosis: Exploring Promising Biomarkers 2023 3rd International Conference on Innovative Sustainable Computational Technologies (CISCT) pp. 1-5, doi: 10.1109/CISCT57197.2023.10351378.
  15. Neetu Rani and Pravir Kumar, "Understanding the role of alkaloids in therapeutic targeting of UBE3A in Alzheimer's Disease," 2023 3rd International Conference on Innovative Sustainable Computational Technologies (CISCT), Dehradun, India, 2023, pp. 1-4, doi:10.1109/CISCT57197.2023.10351490.
  16. Sudhanshu Sharma; Pravir Kumar, Deciphering the Molecular Mechanism of HSP90AB1 as a Potential Heat Shock Protein and Understanding the Role of Alkaloids in the Therapeutic Suppression of Glioblastomas (GBMs) 2023 3rd International Conference on Innovative Sustainable Computational Technologies (CISCT) pp. 1-5, doi: 10.1109/CISCT57197.2023.10351302.
  17. Mehar Sahu; Pravir Kumar RING Domain Mutation Hinders the E3 Ligase Activity of RNF8 and Affects UBE2N Binding 2023 International Conference on Network, Multimedia and Information Technology (NMITCON)  1-6, doi: 10.1109/NMITCON58196.2023.10276155
  18. Jasmeer Singh Kalra, Pravir Kumar, Huntington's Disease Biomarker Discovery: A Computational Approach 2023 5th International Conference on Inventive Research in Computing Applications (ICIRCA) pp. 96-100, doi: 10.1109/ICIRCA57980.2023.10220841.
  19. Shubham Kumar Shrivastav, Pravir Kumar; Histone Deacetylase 6 as a putative target in Alzheimer’s disease therapeutics (Best paper award); IEEE ICASIS-2023 96-100, doi: 10.1109/ICIRCA57980.2023.10220841.
  20. Nancy Sanjay Gupta, Pravir Kumar; TDP-43 Inhibitors in Amyotrophic Lateral Sclerosis: An Application of Drug Repurposing Approach Using FDA Approved Drugs; IEEE-2nd International Conference on Computational Intelligence and Sustainable Engineering Solution (CISES-2023) pp. 202-205, doi: 10.1109/CISES58720.2023.10183592.
  21. Neha Nagvanshi, Pravir Kumar; Repurposing of anti-viral compounds against HDAC6 in Alzheimer’s therapeutics; IEEE-2nd International Conference on Computational Intelligence and Sustainable Engineering Solution (CISES-2023), pp. 1048-1051, doi: 10.1109/CISES58720.2023.10183563
  22. Harsha Jha, Pravir Kumar; Analysing the mechanism of extracellular vesicles and its potential as a biomarker for neurodegenerative disorders, IEEE ICAECIS-2023, pp. 632-636, doi: 10.1109/ICAECIS58353.2023.10170438.
  23. Kumud Kaul, Pravir Kumar; Fate of Jeratinine E as a potential compound to target NNMT protein in countering Parkinson's disease; IEEE -(ICSTSN 2023), pp. 1-5, doi: 10.1109/ICSTSN57873.2023.10151586
  24. Murali Mohan Mishra, Pravir Kumar; Crocin: A potent secondary metabolite as BACE1 inhibitor in Alzheimer’s Disease; IEEE - ICACCS 2023, pp. 1486-1490, doi: 10.1109/ICACCS57279.2023.10112776
  25. Sanya Madan, Pravir Kumar; STILBOSTEMIN C as a potential candidate for therapeutic targeting of RAB3B protein in countering AD; IEEE-Information system and computer network (ISCON-2023), pp. 1-4, doi: 10.1109/ISCON57294.2023.10112094.
  26. Murali Mohan Mishra, Pravir Kumar; Identification and Screening of Novel ACE Inhibitors Using Computational Approach; IEEE-ICCT 2023, pp. 1-4, doi: 10.1109/ICCT56969.2023.10075941.
  27. Dia Advani, Pravir Kumar (2022) Computational Analysis of Natural Compounds as Cyclin Dependent Kinase-5 Inhibitors for Alzheimer's and Parkinson's Disease 2022 IEEE Global Conference on Computing, Power DOI: 10.1109/GlobConPT57482.2022.9938169
  28. Navneet and Pravir Kumar, Putative micro-RNAs in the pathogenesis of Alzheimer’s diseases, IEEE 2022 8thInternational Conference on Advanced Computing and Communication Systems (ICACCS) 25th– 26thMarch 2022 Technically Sponsored by IEEE and IEEE Madras Section (full length paper). DOI: 10.1109/ICACCS54159.2022.9785308
  29. Mayank Sagar and Pravir Kumar, Crosstalk Between Ubiquitination and Acetylation in the Parkinson's Disease, IEEE 2022 8thInternational Conference on Advanced Computing and Communication Systems (ICACCS) 25th– 26thMarch 2022 Technically Sponsored by IEEE and IEEE Madras Section (full length paper). DOI: 10.1109/ICACCS54159.2022.9785234
  30. Divya Yadav, Pravir Kumar, Parkinson’s Disease: An overview and role of glutamate and its receptors, IEEE Information System and Computer Network (ISCON- 2021) conference 22-23 October 2021 (full length paper) DOI: 10.1109/ISCON52037.2021.9702338
  31. Harshita Goswami, Pravir Kumar, Is Artificial Intelligence a Helping Hand for The Future of Neurosurgery? IEEE Information System and Computer Network (ISCON- 2021) 22-23 October 2021 (full length paper), DOI: 10.1109/ISCON52037.2021.9702473
  32. Animan Tripathi, Pravir Kumar, Identification of Putative LRRK2 Inhibitors in the Pathogenesis of Parkinson’s Disease: A Drug-repurposing Approach, IEEE Information System and Computer Network (ISCON- 2021) conference (full-length paper) DOI: 10.1109/ISCON52037.2021.9702406
  33. Yami Garg, Pravir Kumar, Regulation of Hypoxia Inducible Factor via Histone Deacetylase 3 Inhibitor Valproic Acid IEEE Information System and Computer Network (ISCON- 2021) conference 22-23 October 2021 (full-length paper), DOI: 10.1109/ISCON52037.2021.9702407
  34. Manu Gangyan, Pravir Kumar, VEGF and Its Role in the Treatment of Diabetes and Alzhiemer's Disease, IEEE International Conference on Image Information Processing (ICIIP-2021) November 28, 2021 (full-length paper) DOI: 10.1109/ICIIP53038.2021.9702619

 

CONFERENCE AND SYMPOSIUM PRESENTATIONS

(*: Corresponding author)

  1. Nancy and Pravir Kumar* (2024), From Challenge to Solution: Exploring Drug Reprofiling for Neurological Disorders, Recent Advances in Neurochemistry and Neuroscience, Jamia Hamdard, Delhi, India.
  2. Parneet Kaur and Pravir Kumar* (2024), Unravelling the Impact of Physical Exercise: Insights into Neuroinflammation, Neuroplasticity and Neurodegeneration, Recent Advances in Neurochemistry and Neuroscience, Jamia Hamdard, Delhi, India.
  3. Anjali Roy and Pravir Kumar* (2024), From Challenge to Solution: Exploring Drug Reprofiling for Neurological Disorders, Recent Advances in Neurochemistry and Neuroscience, Jamia Hamdard, Delhi, India.
  4. Aastha Kaushik and Pravir Kumar* (2024), Computational Insights into E3 Ligase Modulators Targeting Shared Pathways in Neurodegenerative Diseases and Cancer, Recent Advances in Neurochemistry and Neuroscience, Jamia Hamdard, Delhi, India.
  5. Anistha and Pravir Kumar* (2024), GEPIA2 Analysis Reveals SOX2 as a Potential Therapeutic Target in Glioblastoma, Recent Advances in Neurochemistry and Neuroscience, Jamia Hamdard, Delhi, India.
  6. Akanksha Sahu and Pravir Kumar* (2024), Exploring the Role of SORL1 gene and its pharmacological interactions in Alzheimer's Disease, International Conference on Emerging Technologies in Science and Engineering (ICETSE), Akshay Institute of Engineering, Karnataka, India.
  7. Shrutikirti Vashishth and Pravir Kumar* (2024), Transversing the Crossroads of Antimicrobial Resistance: Unmasking Challenges and Possibilities in Innovative Drug Discovery and Advancements in Vaccines with a Special Focus on the Gut Microbiota, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  8. Anistha and Pravir Kumar* (2024), Utilizing Artificial Intelligence and Machine Learning to Address Antibiotic Resistance in Bacterial Infections for Enhanced Treatment of Neurological Disorders, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  9. Nancy and Pravir Kumar* (2024), Innovative Interplay: Merging Frontiers of Antimicrobial Susceptibility Testing and Nanotechnology to Counteract Antimicrobial Resistance, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  10. Parneet Kaur and Pravir Kumar* (2024), Unraveling the Neurobiology of Antimicrobial Resistance in Central Nervous System Infection, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  11. Anjali Roy and Pravir Kumar* (2024), Navigating the triad : Antimicrobial Resistance, Neuroscience, and Drug Repurposing, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  12. Aastha Kaushik and Pravir Kumar* (2024), In-silico Design and Immunoinformatics Analysis of a Mutation-Resistant SARS-CoV-2 N-Protein Derived Vaccine: Towards Antimicrobial Resistance Mitigation, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  13. Shefali Kardam and Pravir Kumar* (2024), Navigating the Dual Challenge: Antimicrobial Resistance and Parkinson's Disease, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  14. Rahul Tripathi and Pravir Kumar* (2024), Computational Insights into Antimicrobial Resistance in Alzheimer's Disease: Unraveling the Interactions at the Molecular Level, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  15. Mehar Sahu, Pravir Kumar* (2023), E3 Ligase Activity of RNF168 at Stake On Ring Domain Mutation, the World Congress of Neurology (WCN 2023) Journal of the Neurological Sciences, Volume 455.
  16. Mehar Sahu, Pravir Kumar* (2024), Interplay Between AMR Susceptibility Testing Using and Deep Learning: Implication for Drug Development, 3rd International Conference on Antimicrobial Resistance, Novel DrugDiscovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  17. Mehar Sahu, Pravir Kumar* (2024), Interplay Between AMR Susceptibility Testing and Deep Learning: Implication for Drug Development, 3rd International Conference on Antimicrobial Resistance, Novel Drug Discovery and Vaccine Development: Challenges and Opportunities”, Delhi, India 2024.
  18. Neetu Rani and Pravir Kumar* (2023), Leuconoxine as a prospective therapeutic
    candidate targeting CDK6 in combating Alzheimer's disease, the World
    Congress of Neurology (WCN 2023) Journal of the Neurological Sciences
    Volume 455.
  19. Aastha Kaushik and Pravir Kumar* (2023), In-silico insights into phytochemical docking using MARCH 5 structure-homology modelling, AIIMS, IMMUNOCON.
  20. Subham Kumar Srivastava, Pravir Kumar*; Drug repurposing approach to identify PARK7 inhibitors in Parkinson’s Disease (Best paper award); IEEE Bangalore Humanitarian Technology Conference-2023.
  21. Smita Kumari, Pravir Kumar*, Identification of Novel Drug Combination in Glioblastoma Multiforme Therapeutics Through Drug Repurposing, 06/2023 IEEE-2023 International Conference on Emerging Techniques in Computational Intelligence (ICETCI).
  22. Nancy Sanjay Gupta, Pravir Kumar*; DNMT1 inhibitors in Alzheimer’s Disease: A drug repurposing approach through FDA-approved drugs; IEEE BANGLORE HUMANITARIAN TECHNOLOGY CONFERENCE B-HTC 2023.
  23. Harsha Jha, Pravir Kumar*; Comparative Analysis of Novel Biomarkers For Neurodegenrative Disease;4th International Conference On Emerging Trends in Multi-Disciplinary Research (ETMDR-2023).
  24. Twinkle Yadav, Pravir Kumar*; Repurposing breast cancer medications for sleep and neurodevelopmental disorders; IEEE BANGLORE HUMANITARIAN TECHNOLOGY CONFERENCE (B-HTC 2023).
  25. Shallu Chauhan, Pravir Kumar*; A Prediction of Pecilocin as A Potential Therapeutic Regime in Countering Glioblastoma Using Computational Approach; IEEE BANGLORE HUMANITARIAN TECHNOLOGY CONFERENCE (B-HTC 2023)
  26. Tanya Kalra, Pravir Kumar*; Identification of novel therapeutic compounds against Diabetic nephropathy: A drug repurposing approach; IEEE BANGLORE HUMANITARIAN TECHNOLOGY CONFERENCE (B-HTC 2023)
  27. Shanu Bhardwaj, Pravir Kumar*; Targeting GSK-3β for the Modulation of Wnt Signaling Pathway in Alzheimer’s Disease: A Drug Repurposing Approach; IEEE BANGLORE HUMANITARIAN TECHNOLOGY CONFERENCE (B-HTC 2023).
  28. Neetu Rani and Pravir Kumar*  (2024), Revolutionizing Antimicrobial Defence: Unleashing CDK5 as a Molecular Maestro Against Drug Resistance, 3rd International Conference on Antimicro

BOOKS/BOOK CHAPTERS (IF ANY)

  1. Dia Advani, Sudhanshu Sharma, Rahul Tripathi, Rohan Gupta, Asmita Jaiswal, Rashmi K Ambasta, Pravir Kumar*, (2021) Mitochondrial dysfunction in metabolic disorders, Mitochondrial Dysfunction and Nanotherapeutics (Elsevier) 978-0-323-85666-9 B978-0-323-85666-9.00015-2
  2. RohanGupta, Rashmi K.Ambasta, PravirKumar (2021), Mitochondrial dysfunction and autophagy inneurodegeneration; Mitochondrial Dysfunction and Nanotherapeutics (Elsevier) 978-0-323-85666-9 B978-0-323-85666-9.00019-X
  3. Rohan Gupta, Rashmi K Ambasta, Pravir Kumar*, (2020) Mitochondrial dysfunction and autophagy in neurodegeneration, Mitochondrial Protection for Health and Aging (Chapter 13), Elsevier – Invited
  4. Sudhanshu Sharma, Rahul Tripathi, Dia Advani, Rohan Gupta, Rashmi K Ambasta, Pravir Kumar*, (2020) Mitochondrial metabolism in neurological disorders, Mitochondria in Neurological Disorders (Chapter 9) Elsevier- Invited
  5. Pravir Kumar*, Rashmi K Ambasta, Aditi Sarkar, Abhidha Kohli and Kushi Anand, (2012) Combinatorial effect of heat Shock protein and ubiquitin proteasome system in neuro-oncology Signaling, Gene Regulation and Cancer, 287-316 (*corresponding author) (Signaling, gene regulation and cancer, Nova Science Publishers, New York, USA; INVITED: ISBN: 978-1-61942-088-5;
  6. Pravir Kumar*, Rashmi K Ambasta, M. Sonia Angeline Inbakumari and Mandar Bhattacharya, (2012) Post-mitotic expression of cyclins in neuro-oncogenesis: a fatal journey by cells Signaling, Gene Regulation and Cancer, 255 - 286 (*corresponding author)
  7. Rashmi K Ambasta, Pravir Kumar*, Archita Sharma and Esther Priyadarshini S. (2012) Notch Signalling regulates cancer stem cells and tumour angiogenesis, Signaling, Gene Regulation and Cancer, 223 - 254 (*co-corresponding author).
  8. Rashmi K. Ambasta, Dhiraj Kumar, Piyush Sawhney, Rajat Gupta, Parul Yadav, Pooja Pabari and Pravir Kumar*(2016) Epigenesis in Colorectal Cancer: A lethal change in the cell, Epigenetic Advancements in Cancer, Edited by Manoj Mishra, Kumar Bishnupuri, 12/2015: chapter Book Chapter; Springer International publishing AG DOI: 10.1007/978-3-319-24951-3 http://www.springer.com/in/book/9783319249490
  9. Ankit Tripathi, Renu Sharma, Noopur Kejriwal, Rashmi K Ambasta and Pravir Kumar*(2016), Epigenetic post transcriptional mutation in neuro-oncology, Epigenetic Advancements in Cancer, Edited by Manoj Mishra, Kumar Bishnupuri, 12/2015: chapter Book Chapter; Springer International publishing AG. DOI: 10.1007/978-3-319-24951-3 http://www.springer.com/in/book/9783319249490
  10. Niraj Kumar Jha, Saurabh Kumar Jha, Satyaprakash, Rohan Kar, Deepak Rathore, Rashmi K Ambasta and Pravir Kumar*(2016) Epigenetics and angiogenesis in cancer, Epigenetic Advancements in Cancer, Edited by Manoj Mishra, Kumar Bishnupuri, 12/2015: chapter Book Chapter; Springer International publishing AG. DOI: 10.1007/978-3-319-24951-3 http://www.springer.com/in/book/9783319249490

PATENTS (IF ANY)

HONOURS AND AWARDS (IF ANY)

 

  1. Advisor, Confidential work of Government of India
  2. Selection Committee member, for Assistant Professor, Associate Professor and full professor for many Indian universities
  3. Member Toxicology and Pharmacology Division, Indian Council of Medical Research (ICMR), Ministry of Health, Government of India
  4. Member-International Fellowship Division, Indian Council of Medical Research (ICMR), Ministry of Health, Government of India
  5. Citations and commendable researcher award- Silver (2023) and Gold (2024) for high citations, Delhi Technological Univesity
  6. Recipient: Commendable researcher award 2018, 2020, 2021, 2022, 2023, 2024 by Delhi Technological University
  7. Winner, Yearly citations and impact citation award (2023, 2024, 2025), Delhi Technological Univesity
  8. Associate Editor: Ageing Research Review (only Indian in the editorial Board)-2024
  9. Specialist panel, Soldier Health & Drug Development (SH&DD) Panel, DRDO Ministry of Defense, Government of India (2018-2021)
  10. Member, National selection committee USIEF-Fulbright program
  11. Executive committee member, National Research Development Corporation (NRDC), Ministry of Science and Technology, Government of India
  12. Ad hoc Grant Reviewer, SERB-DST Board, Government of India
  13. Adhoc Grant Reviewer, Department of Biotechnology, Government of India
  14. Faculty expert, e-PG Pathshala (an initiative of University grant commission GC and MHRD, Government of India)
    1. P-04. Genetic Engineering and recombinant DNA technology: (36 Modules)
    2. Online course development; https://epgp.inflibnet.ac.in/; Please select module 3; 11; 22; 23; 24; 26.

MEDIA COVERAGE:

SPONSORED/CONSULTANCY PROJECTS

RESEARCH GRANTS

(Key words: Hypoxia, Anti-cancer drug, Anti-angiogenics substance, Therapeutics)

2009-2012: Life Scince Research Board (LSRB)-Defense Research and Development Organization grant: “Functional Role of Heat Shock Proteins and Ubiquitin E3 Ligase under Hypoxic Stress Conditions” LSRB-200/EPB/2009 (Role: Principal investigator) recipient PROJECT COMPLETED; Amount 15000 USD (approx.)-Hypoxia signaling

2013- 2016: Department of Science and Technology (DST) GRANT: Identification and characterization of anti-cancerous and anti-angiogenic biomolecules for colon cancer” June 2013-June 2016; (PI: Dr. Rashmi Ambasta; Mentor: Prof. Pravir Kumar) Amount-Rs. PROJECT COMPLETED; Amount 27000 USD (approx.)-Colon Cancer

2016- 2019:Council of Scientific and Industrial Research (CSIR) GRANT: Screening and Investigation of biomolecules for therapy of Diabetes via cell culture method. (PI: Dr. Rashmi Ambasta; Mentor: Prof. Pravir Kumar) July 2016-2019; PROJECT COMPLETED; Amount 23000 USD (approx.)-Therapeutics and signaling

START-UPS (IF ANY)

MOOC COURSES DEVELOPED (IF ANY)

  1.  Faculty expert, e-PG Pathshala (an initiative of University grant commission GC and MHRD, Government of India)
    1. P-04. Genetic Engineering and recombinant DNA technology: (36 Modules)
    2. Online course development; https://epgp.inflibnet.ac.in/; Please select module 3; 11; 22; 23; 24; 26

PROFESSIONAL DEVELOPMENT

ADVISEES

ANY OTHER INFORMATION

PROFESSIONAL INFORMATION

Professor-11th years in progress, Associate Professor- 07 years; Administrative experience: 13 years; Research experience-22 years, Teaching experience: 16 years, Highly proficient in wet lab experimentations related to genomics, molecular biology, genetic engineering, human samples (Autopsy and Biopsy), mammalian cell cuture, and proteomics. Mentored several PhD and MS students in the molecular medicine; cancer biology and neurobiology, curriculum designer, key member- confidential work of government of India. Associate Editor, Ageing Research Review (June 2024-June 2027; sole editorial board member from India) Publications record: ?Pravir Kumar - ?Google Scholar; Pravir Kumar - Search Results - PubMed (nih.gov)

 

LEADERSHIP ROLE

Dean (International Affairs 2022-present), Dean (Alumni Affairs, 2018-2021), Chair (Department of Biotechnology 2021-2023), Assistant Director (center), Chairman (Dec 2019-Dec 2023), Departmental Research Committee, DTU; Chairman (Jan 2021-Dec 2023), Board of Studies, DTU; National Expert member (2019-2022) Soldiers health and drug discover (SHDD), Defense Research and Development Organization, Ministry of Defense, Government of India; National Expert member United States India Educational Foundation (USIEF), Fulbright programme; National Expert member (2022-present)-Toxicology and Pharmacology Division, Indian Council of Medical Research (ICMR), Ministry of Health, Government of India; National Expert member (2022-present)-International Fellowship Division, Indian Council of Medical Research (ICMR), Ministry of Health, Government of India; Chairman (2021-2023)-Departmental purchase committee, DTU; Vice Chairman and Core member  Joint admission committee, DTU; Assistant Director- Centre for Medical Engineering at Vellore Institute of Technology (VIT), Vellore; Advisor- Confidential work of Government of India, Member of Selection panel in Assistant Professor, Associate Professor and Professor (Confidential)

REVIEWING AND EDITORIAL ASSIGNMENTS

EDITORIAL BOARD MEMBERS

Associate Editor, Ageing Research Reviews (Elsevier, IF: 12.4); Editor, Scientific Reports (Nature Publication house); Associate Editor, Journal of Alzheimer's Disease (2014- July 2020; IOS press); Review Editor, Frontier Drug discovery, Editor, International Journal of Neurology Research; Editor, International Journal of Hematology Research; Editor, Journal of Clinical Trials and Patenting; Associate Editor, American Journal of Research Communication; Associate Editor, Advances in Obesity, Weight Management & Control; Editor, International Journal of Advanced Biotechnology and Bioinformatics; Academic Editor, International journal of Bioinformatics; Editor, SOJ Biotechnology

REVIEWERS ASSIGNMENTS

NATURE Nature Chemical Biology, Nature communication, Scientific Reports ELSEVIER Ageing Research Reviews, Biomaterial Acta, Pharmacology & Therapeutics, Advanced Drug Delivery Reviews, Journal of Nutritional Biochemistry; BBA-Molecular Basis of disease; Brain Research; Life Sciences; Behaviour Brain Research; Environmental Research; Neurochemistry International; Brain, Behaviour and Immunity; Multiple Sclerosis and Related Disorders; Informatics in medicine unlocked, Computers in Biology and Medicine SPRINGER Cellular and Molecular Life Science; Cellular and Molecular Neuroscience; Journal of Genetics; Translational Neurodegeneration (BMC/Springer); Molecular Brain, Molecular Diversity OXFORD, CELL, ACS, BMC, WILEY, TRANSACTION, BENTHAM AND OTHERS Briefing in Bioinformatics (Oxford), iScience (Cell press), Journal of Agricultural and Food Chemistry (ACS publication); PlosOne; Neural Regeneration Research; DARU journal of Pharmaceutical Sciences (BMC journal); Current Medicinal Chemistry (Bentham); Bentham Direct; Current Computer-Aided Drug Design (Bentham); Cellular Physiology and Biochemistry (KARGER); Journal of Young Pharmacy; Oncotarget; Indian Journal of Medical Research; Annals of Clinical and Translational Neurology (Wiley); ChemMedChem (Wiley); Journal of Neurochemistry (Wiley), Motor Neuron Disorders (MND), United Kingdom; Biochemical Society Transaction; Science Progress (SAGE), Frontiers in Ageing Neuroscience; Expert review of Proteomics (Taylor and Francis); Cell Biology International (Wiley); Journal of clinical medicine (MDPI)

ADMINISTRATIVE EXPEREINCE

Dean (Sep 2022-present), International affairs, Delhi Technological University (NCT Government of Delhi), Chair/HoD (Jan 2021-Dec 2023), Department of Biotechnology, Delhi Technological University (NCT Government of Delhi), Former Dean (Jan 2018-March 2020), Alumni affairs Delhi Technological University (NCT Government of Delhi); -

RESPONSIBILITIES IN ADMINISTRATIVE POSITIONS

 

DEAN (INTERNATIONAL AFFAIRS, DTU)

  • Admission of overseas students through Direct Admission of Students Abroad (DASA), Indian Council for Cultural Relations (ICCR; Ministry of external Affairs); Study in India (SII; Ministry of Education (MoE) program.
  • Issuance of visa papers Foreigners Registration Office (FRRO), migration certificates, Bona fide certificates, degree certificates
  • Liasioning between government of India, overseas institutions, and Delhi Technological University (DTU) for enabling student’s intake, MoUs/MoAs (DTU and foreign university), exchange programs (between partner university).
  • Close interaction between government bodies such as Ministries of Government of India, DTU and funding agencies
  • Close association and interaction with foreign diplomats and consular general of India in overseas
  • Implementation of twining, double and dual programmes in cooperation with UGC and overseas university
  • Generation of demand notes to release fellowship of all overseas admitted students to DTU and other financial obligations of foreign students from funding agencies and government bodies.
  • Close association of my office at DTU, Police Department and Ministry of home affairs (government of India) for the protection, checking activities and security of foreign nationals.
  • Preparation and implementation of new rules, norms and directions received from the Government of India and Directorate of Training and Technical Education (DTTE).
  • Establishing relationships with DTU and Embassies of different countries
  • Event arrangement and handling of cultural events, international students meet, their cultural programs and other activities
  • Troubleshooting of international students day-to day issues related to academics, hostel, and sometime personal issues as well.

DEAN (ALUMNI AFFAIRS, DTU)

  • Established a strong relationship between around 40000 alumni of DP/DCE/DTU.
  • Created many networks/groups to maintain one-to-one interactions.
  • Organized two homecoming alumni meetings of 1969 and 1970 batches at DTU campus.
  • Generated over 6 crores funds from alumni of DCE/DTU

HoD/Chair (DEPARTMENT OF BIOTECHNOLOGY, DTU)

  • Served as the chairman for the Board of studies (BOS), Department research committee (DRC), Department purchase committee (DPC)
  • Extension of NBA accreditation (till June 2024)
  • Development of four new teaching laboratories (Laboratory of Medical Biotechnology and therapeutics, Laboratory of Bioremidiation and industrial application, Laboratory of coding and Biological informatics and Laboratory of Network Biology)
  • Double the intake of seats in M.Sc. Biotechnology

PEER-REVIEWED CONFERENCE PUBLICATIONS-IEEE FULL LENGTH CONFERENCE PAPERS

(Pravir Kumar - IEEE Xplore Author Profile)

R. Mrinal and P. Kumar, "Integrating Machine Learning and Gene Expression Analysis for Dementia Subtype Classification and Biomarker Discovery," 2025 International Conference on Advances in Modern Age Technologies for Health and Engineering Science (AMATHE), Shivamogga, India, 2025, pp. 1-6, doi: 10.1109/AMATHE65477.2025.11081300.

  • H. Vardhan and P. Kumar, "In silico analysis of deleterious p53 SNPs in Parkinson’s Disease," 2025 International Conference on Ambient Intelligence in Health Care (ICAIHC), Raipur Chattisgarh, India, 2025, pp. 1-5, doi: 10.1109/ICAIHC64101.2025.10957514.
  • P. Kaur and P. Kumar, "Bioinformatics-Guided Drug Repurposing for Precision Management of Parkinson’s Disease: Targeting the LRRK2 G2019S," 2024 International Conference on Communication, Computing and Energy Efficient Technologies (I3CEET), Gautam Buddha Nagar, India, 2024, pp. 34-39, doi: 10.1109/I3CEET61722.2024.10993568.
  • R. Mrinal and P. Kumar, "In Silico Identification of Novel GABRA2 Inhibitors Leveraging the Power of Virtual Screening," 2024 IEEE 11th Uttar Pradesh Section International Conference on Electrical, Electronics and Computer Engineering (UPCON), Lucknow, India, 2024, pp. 1-6, doi: 10.1109/UPCON62832.2024.10983394.
  • Apurva and P. Kumar, "In silico Analysis for Potential SIRT2 Inhibitors," 2024 2nd International Conference on Advances in Computation, Communication and Information Technology (ICAICCIT), Faridabad, India, 2024, pp. 474-479, doi: 10.1109/ICAICCIT64383.2024.10912162.
  • S. Verma and P. Kumar, "Computational Approach for Prediction of NMDA antagonist in Huntingtin’s Disease," 2024 OPJU International Technology Conference (OTCON) on Smart Computing for Innovation and Advancement in Industry 4.0, Raigarh, India, 2024, pp. 1-6, doi: 10.1109/OTCON60325.2024.10688037.
  • Ashima Gulia and Pravir Kumar, "Comparative Docking Strategies for Alzheimer’s Therapy: Exploring Drug and Phytocompound Interactions with BIN1 Protein," 2024 4th International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE), Greater Noida, India, 2024, pp. 1895-1899, doi: 10.1109/ICACITE60783.2024.10617309.
  • Shikha Kadyan and Pravir Kumar, "Analyzing speech patterns for Parkinson’s diagnosis: Insights from ML models," 2024 4th International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE), Greater Noida, India, 2024, pp. 1904-1909, doi: 10.1109/ICACITE60783.2024.10617205.
  • Pallavi and Pravir Kumar, "Employing Multifaceted Bioinformatics Strategies for the Discovery of Novel ASK1 Inhibitors Targeting Neurodegenerative Disorders," 2024 International Conference on Knowledge Engineering and Communication Systems (ICKECS), Chikkaballapur, India, 2024, pp. 1-5, doi: 10.1109/ICKECS61492.2024.10616397.
  • Ashish and Pravir Kumar, "Pharmacoinformatic-guided Drug Reprofiling for Unveiling of NovelBioactive Inhibitors Targeting USP13 in the Treatment of Parkinson’s Disease," 2024 International Conference on Knowledge Engineering and Communication Systems (ICKECS), Chikkaballapur, India, 2024, pp. 1-5, doi: 10.1109/ICKECS61492.2024.10616774.
  • Anjali Roy and Pravir Kumar, "Unravelling Parkinson’s Disease Therapeutics: Computational Insights into VPS35 via Drug Repurposing," 2024 International Conference on Knowledge Engineering and Communication Systems (ICKECS), Chikkaballapur, India, 2024, pp. 1-5, doi: 10.1109/ICKECS61492.2024.10616510.
  • Anistha, Pravir Kumar, Revolutionizing Glioblastoma Treatment: In Silico Discovery Targets SOX2 Gene through Molecular Docking, Unveiling Potential of Cosmegen and Repurposed Penfluridol, 2024 International Conference on Automation and Computation (AUTOCOM) 197-201, doi: 10.1109/AUTOCOM60220.2024.10486129.
  • Aastha Kaushik, Pravir Kumar In-Silico Structural Analysis of Membrane-Associated RING-CH Type 2 (MARCH 2) Protein 2023 International Conference on Integration of Computational Intelligent System (ICICIS) pp. 1-6, doi: 10.1109/ICICIS56802.2023.10430285
  • Aastha Kaushik, Pravir Kumar In-Silico Analysis for Differentially Expressed Genes in Multiple Sclerosis: Exploring Promising Biomarkers 2023 3rd International Conference on Innovative Sustainable Computational Technologies (CISCT) pp. 1-5, doi: 10.1109/CISCT57197.2023.10351378.
  • Neetu Rani and Pravir Kumar, "Understanding the role of alkaloids in therapeutic targeting of UBE3A in Alzheimer's Disease," 2023 3rd International Conference on Innovative Sustainable Computational Technologies (CISCT), Dehradun, India, 2023, pp. 1-4, doi:10.1109/CISCT57197.2023.10351490.
  • Sudhanshu Sharma; Pravir Kumar, Deciphering the Molecular Mechanism of HSP90AB1 as a Potential Heat Shock Protein and Understanding the Role of Alkaloids in the Therapeutic Suppression of Glioblastomas (GBMs) 2023 3rd International Conference on Innovative Sustainable Computational Technologies (CISCT) pp. 1-5, doi: 10.1109/CISCT57197.2023.10351302.
  • Mehar Sahu; Pravir Kumar RING Domain Mutation Hinders the E3 Ligase Activity of RNF8 and Affects UBE2N Binding 2023 International Conference on Network, Multimedia and Information Technology (NMITCON)  1-6, doi: 10.1109/NMITCON58196.2023.10276155
  • Jasmeer Singh Kalra, Pravir Kumar, Huntington's Disease Biomarker Discovery: A Computational Approach 2023 5th International Conference on Inventive Research in Computing Applications (ICIRCA) pp. 96-100, doi: 10.1109/ICIRCA57980.2023.10220841.
  • Shubham Kumar Shrivastav, Pravir Kumar; Histone Deacetylase 6 as a putative target in Alzheimer’s disease therapeutics (Best paper award); IEEE ICASIS-2023 96-100, doi: 10.1109/ICIRCA57980.2023.10220841.
  • Nancy Sanjay Gupta, Pravir Kumar; TDP-43 Inhibitors in Amyotrophic Lateral Sclerosis: An Application of Drug Repurposing Approach Using FDA Approved Drugs; IEEE-2nd International Conference on Computational Intelligence and Sustainable Engineering Solution (CISES-2023) pp. 202-205, doi: 10.1109/CISES58720.2023.10183592.
  • Neha Nagvanshi, Pravir Kumar; Repurposing of anti-viral compounds against HDAC6 in Alzheimer’s therapeutics; IEEE-2nd International Conference on Computational Intelligence and Sustainable Engineering Solution (CISES-2023), pp. 1048-1051, doi: 10.1109/CISES58720.2023.10183563
  • Harsha Jha, Pravir Kumar; Analysing the mechanism of extracellular vesicles and its potential as a biomarker for neurodegenerative disorders, IEEE ICAECIS-2023, pp. 632-636, doi: 10.1109/ICAECIS58353.2023.10170438.
  • Kumud Kaul, Pravir Kumar; Fate of Jeratinine E as a potential compound to target NNMT protein in countering Parkinson's disease; IEEE -(ICSTSN 2023), pp. 1-5, doi: 10.1109/ICSTSN57873.2023.10151586
  • Murali Mohan Mishra, Pravir Kumar; Crocin: A potent secondary metabolite as BACE1 inhibitor in Alzheimer’s Disease; IEEE - ICACCS 2023, pp. 1486-1490, doi: 10.1109/ICACCS57279.2023.10112776
  • Sanya Madan, Pravir Kumar; STILBOSTEMIN C as a potential candidate for therapeutic targeting of RAB3B protein in countering AD; IEEE-Information system and computer network (ISCON-2023), pp. 1-4, doi: 10.1109/ISCON57294.2023.10112094.
  • Murali Mohan Mishra, Pravir Kumar; Identification and Screening of Novel ACE Inhibitors Using Computational Approach; IEEE-ICCT 2023, pp. 1-4, doi: 10.1109/ICCT56969.2023.10075941.
  • Dia Advani, Pravir Kumar (2022) Computational Analysis of Natural Compounds as Cyclin Dependent Kinase-5 Inhibitors for Alzheimer's and Parkinson's Disease 2022 IEEE Global Conference on Computing, Power DOI: 10.1109/GlobConPT57482.2022.9938169
  • Navneet and Pravir Kumar, Putative micro-RNAs in the pathogenesis of Alzheimer’s diseases, IEEE 2022 8thInternational Conference on Advanced Computing and Communication Systems (ICACCS) 25th– 26thMarch 2022 Technically Sponsored by IEEE and IEEE Madras Section (full length paper). DOI: 10.1109/ICACCS54159.2022.9785308
  • Mayank Sagar and Pravir Kumar, Crosstalk Between Ubiquitination and Acetylation in the Parkinson's Disease, IEEE 2022 8thInternational Conference on Advanced Computing and Communication Systems (ICACCS) 25th– 26thMarch 2022 Technically Sponsored by IEEE and IEEE Madras Section (full length paper). DOI: 10.1109/ICACCS54159.2022.9785234
  • Divya Yadav, Pravir Kumar, Parkinson’s Disease: An overview and role of glutamate and its receptors, IEEE Information System and Computer Network (ISCON- 2021) conference 22-23 October 2021 (full length paper) DOI: 10.1109/ISCON52037.2021.9702338
  • Harshita Goswami, Pravir Kumar, Is Artificial Intelligence a Helping Hand for The Future of Neurosurgery? IEEE Information System and Computer Network (ISCON- 2021) 22-23 October 2021 (full length paper), DOI: 10.1109/ISCON52037.2021.9702473
  • Animan Tripathi, Pravir Kumar, Identification of Putative LRRK2 Inhibitors in the Pathogenesis of Parkinson’s Disease: A Drug-repurposing Approach, IEEE Information System and Computer Network (ISCON- 2021) conference (full-length paper) DOI: 10.1109/ISCON52037.2021.9702406
  • Yami Garg, Pravir Kumar, Regulation of Hypoxia Inducible Factor via Histone Deacetylase 3 Inhibitor Valproic Acid IEEE Information System and Computer Network (ISCON- 2021) conference 22-23 October 2021 (full-length paper), DOI: 10.1109/ISCON52037.2021.9702407
  • Manu Gangyan, Pravir Kumar, VEGF and Its Role in the Treatment of Diabetes and Alzhiemer's Disease, IEEE International Conference on Image Information Processing (ICIIP-2021) November 28, 2021 (full-length paper) DOI: 10.1109/ICIIP53038.2021.9702619

INVITED PRESENTATIONS

 

  1. (2024)- Society for neurochemistry India (SNCI)-Annual meeting held in Jamia Hamdard University- Institute of eminence (IoE) [SPEAKER AND SESSION CHAIR]
  2. (2023) Neurological complications and its reversal mechanism in hypoxia-induced mice model, Department of Science and Technology, Govt. of India initiated Synergistic Training Program utilizing the Scientific and Technological infrastructure STUTI: 30.01.2023-05.02.2023; Department of Toxicology, School of Chemical Life Sciences [SPEAKER AND SESSION CHAIR].
  3. (2022) Ubiquitin proteasome system and PTMs in neuronal disorders Department of Science and Technology, Govt. of India initiated Synergistic Training Program utilizing the Scientific and Technological infrastructure STUTI (a two-fold program), 20th – 26th December, 2022 in Dept. of Toxicology, Jamia Hamdard University [SPEAKER AND SESSION CHAIR].
  4. (2022) Consequences of altered level of cell cycle proteins in post mitotic divided neurons and muscles University of Hyderabad is jointly organizing the International Brain Research Organization (IBRO) – APRC Associated sponsored School along with the Society for Neurochemistry, India (SNCI). Understanding pathophysiology of Pain and cognition using animal experiments from 12th to 16th December 2022. [SPEAKER AND SESSION CHAIR].
  5. (2022), Progression and drug treatment for the reversal of neurodegenerative disorders Synergistic Training program Utilizing the Scientific and Technological Infrastructure (STUTI) Program, Department of Applied Physics, Delhi Technological University, 16.11.2022-22.11.2022 [RESOURCE PERSON].
  6. (2022) Glimpses of Cell Culture Work: Standard Operating Procedures and Limitations Synergistic Training programme Utilizing the Scientific and TechnologicalInfrastructure (STUTI) Program, Department of Toxicology, SAS, VIT, Vellore on 13.10.2022 [SPEAKER AND RESOURCE PERSON].
  7. (2022) Protein misfolding, aggregation in neurodegenerative disorders and its reversal through biomolecules, Recent trends in Brain research: Unlocking the mysteries IBRO symposium in collaboration with IAN Delhi Chapter at Department of physiology and promotive health, Institute of Home Economics, University of Delhi, India 22-23.03.2022
  8. (2022), Proteinopathy and UPS machinery in neurodegenerative disorders: biomolecules mediated therapeutics, SNCI chapter meeting, Neurochemical Legacy of Neurological, Disorders: Brainstorming of Novel Approaches 09.03.2022, Jamia Hamdard University [SPEAKER AND SESSION CHAIR]
  9. (2022) Synergistic Training program Utilizing the Scientific and Technological Infrastructure (STUTI) Program” DST STUTI programme [RESOURCE PERSON].
  10. (2021), Ubiquitination and PTM in AD and other NDDs IBRO-APRC Associate School on “Biophysical to Molecular Techniques: An interface in Neurobiology Research” (December 08-13, 2021) 35th SNCI National Workshop on "Advanced Research Techniques for Cellular and Molecular Systems in Neuroscience" (09.12.2021), at Jamia Hamdard University, Delhi, India.
  11. (2021), Ubiquitination and PTM in AD and other NDDs IBRO-APRC Associate School on “Biophysical to Molecular Techniques: An interface in Neurobiology Research”(August 23-27, 2021) Department of Zoology Indira Gandhi National Tribal University, Amarkantak (MP), India.
  12. (2021), Artificial intelligence and machine learning in drug designing and medicine", July 30-31, 2020), two-day webinar on “Drug discovery and development with Machine learning and Artificial intelligence” National Institute of Pharmaceutical Education and Research (NIPER), Kolkata
  13. (2020), Post translational modifications in Neurological disorders, 34th annual conference on SNCI, December 11-13, 2020), University of Hyderabad [SPEAKER AND SESSION CHAIR]
  14. (2019), Physiological stressors and pharmacological intervention in neurodegenerative disorders ", 3rd National conference on Biotechnology and Bioengineering, Innovation and advancement for sustainable future, November 07-09, 2019),
  15. (2019), Ubiquitination mechanism in Alzheimer’s and other neurodegenerative disorders, International Conference on " Frontiers in Neuroscience and Neurochemistry: Dynamic Challenges and Approaches, 33rd Annual Meeting of Society for Neurochemistry (SNCI-ACNN, Jamia Hamdard, October 10-13, 2019), [SESSION CHAIR]
  16. (2019), Ubiquitin E3 ligases, stress proteins, biomolecules and Neurodegenerative disorders, Department of Biomedical Engineering, University of South Florida, USA 05th March 2019
  17. (2019), Physiological and pharmacological stimulus in the Neurodegenerative disorders, Department of biomedical engineering, Cullen College of Engineering, University of Houston, Texas, USA, 04th March 2019
  18. (2018), Ubiquitin proteasome system in neurodegenerative disorders, International conference on emerging researches in bioscience (ICERB), Guru Ghasidas Vishwavidyalaya, koni, Bilaspur (CG) India October 28-30, 2018
  19. (2018), Characterization and mechanistic role of biomoleucles in the reversal of stress induced neurodegeneration Informatics tools in Drug discovery and Drug delivery (ITDDD-2018)-1st to 4th November
  20. (2018), TEQIP-III sponsored short-term training programme on Health, Human values, ethics and Empowerment programme on Recent Developments in translational medicine (RDTM-2018) April 13-18, 2018 at Delhi Technological University (DTU) India
  21. (2018), TEQIP-III sponsored one-week Faculty Development programme on Recent Developments in translational medicine (RDTM-2018) March 12-16, 2018 at Delhi Technological University (DTU) India
  22. (2017), World Neurocongress-2017, An international conference om Neurodegeneration and stem cell therapy, 9-10th December 2017, Aligarh Muslim University (AMU) India
  23. (2017), Biogenesis V conducted by IILM-CET, Greater Noida, India on “Insights and innovations in biotechnology”, 2-3 August 2017
  24. (2017), Characterization and mechanistic role of biomolecules in the reversal of stress induced neurodegeneration, IIIT-Delhi 3rd March http://ccb.iiitd.ac.in/CCB-group-meeting.html
  25. (2016), Physiology behind neurodegenerative disorders, National Conference on Innovation in life science and environment Recent Trends in Biotechnology, Madhya Pradesh Council of Science and Technology (MPCST), VISM, Gwalior 17-18 December [KEYNOTE SPEAKER]
  26. (2016), Relevance of Biomedical Engineering in Neuronal Pathophysiology National Conference on Recent Trends in Biotechnology, Madhya Pradesh Council of Science and Technology (MPCST), VISM, Gwalior 30-31 January [KEYNOTE SPEAKER]
  27. (2015) Differential expression of stress and neuro protective proteins under the influence of flavonoids 29th Annual Conference of Society for Neurochemistry India and Advancement in computation Neurochemistry and Neurobiology (SNCI-ACNN), December 19-21, 2015, NEHU Shillong [SPEAKER AND SESSION CHAIRED]
  28. (2015), Restoration of protective neuroproteins and reversal of symptoms under stress induced neurodegeneration, International Symposium on Neuroscience research from mechanism to application, XXXIII Annual Conference of the Indian Academy of Neurosciences, October 31- November 02, Punjab University, Chandigarh, INDIA [Symposium speaker]
  29. (2015), Therapeutic relevance of ubiquitin E3 ligase, molecular chaperones and bioflavonoids in neurodegenerative disorders, 6th World congress on biotechnology, New Delhi, October 5th -7th, 2015 [SPEAKER AND SESSION CHAIR]: Biotechnology in health care]
  30. (2015), Clinical application of protective proteins and biomolecules in neurodegenerative disorders, Centre for Interdisciplinary Research in Basic Sciences, JMI University (07/08/2015) University Jamia Millia Islamia, New Delhi, 5th May to 25th May, 2015
  31. (2015), Therapeutic approaches in neurodegenerative disorders through biomolecules and Engineering tools, UGC-Academic Staff College, University Jamia Millia Islamia, New Delhi, 5th May to 25th May, 2015 [RESOURCE PERSON]
  32. (2015), Impact of Biomedical Engineering in Neurosciences 2nd workshop on advanced materials and instrumentation in Bio medical engineering (AMIBE 2015), IIIT, Allahabad
  33. (2014), Pathophysiology behind Alzheimer’s Disease, TEQIP-II sponsored two weeks FDP on Frontiers in Chemical and Polymer Sciences 15th-26th December, 2014; DTU, Delhi
  34. (2014), Abrogated cell cycle entry and neuro-muscular degeneration: a lethal move by cell. International Symposium on Translational Neuroscience and XXXII Annual Conference of the Indian Academy of Neurosciences, 01-03 November, NIMHANS Bangalore, INDIA
  35. (2013), Computational analysis of signaling and protein-protein interaction network in Diabetes, NCRTPSB 2013, JMI 16-18 December, INDIA
  36. (2013), Therapeutic role of biomolecules in Parkinson’s disease, International conference of Recent advances in molecular mechanism of neurological disorders, February, 2013, All India Institute of Medical Sciences (AIIMS), New Delhi, INDIA [SPEAKER AND SESSION CHAIR]
  37. (2013), Clinical implication and reversal of hypoxia induced neurodegeneration using flavonoids, National conference on “Emerging trends and Challenges in the Basic and Translational Research in Biochemistry February 4-5, 2013, Banaras Hindu University, Varanasi, INDIA [Coverage of my talk in the leading Newspapers]
  38. (2012), Molecular Chaperones and Ubiquitin E3 Ligase mediated attenuation of β-amyloid, International interdisciplinary science conference -2012 on protein folding and diseases December 8-10, 2012, Jamia Milia Islamia University, Delhi, INDIA.
  39. (2012), “Co-operative action of molecular chaperones, proteasome and E3 ligase on beta-amyloid precursor proteins processing” 3rd international conference of bioinformatics and system biology (INCOBS), 16-18 th February, Annamalai University, Chidambaram, TN, INDIA
  40. (2012) Ubiquitin proteasome system and Neurodegenerative disorders: Does Parkin Ubiquitinate A beta 1-42? 26th Annual meeting of Society for Neurochemistry, India (SNCI)” 9th -11th January, Nagpur, INDIA (PLENARY LECTURE)
  41. (2011) Enhanced level of cyclins Enhanced expression of cyclins and caspases in inclusion body myositis (IBM) and Alzheimer’s diseases (AD), 25th Annual meeting of Society for Neurochemistry, India (SNCI) Silver jubilee celebrations and International Symposium on “Metabolic signaling in Brain in health and Disease” 7th -9th January, Hyderabad, INDIA
  42. (2009) Involvement of molecular chaperones and cross functional ligase CHIP and Parkin in Alzheimer’s and Parkinson’s disease. International conference on Neuroscience Update; Department of Neuroscience, Cochin University of Science and Technology, Kerala, December, INDIA
  43. (2009) Molecular mechanism of chaperones and ubiquitin E3 ligase in neurodegenerative disorders, National Conference on biotechnology for human development, Society for Biotechnologists India (SBTI), Vellore, November INDIA